MAPKAPK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O00170 | S159 | Sugiyama | AIP XAP2 | DALQQNPQPLIFHMEMLKVEsPGtYQQDPWAMTDEEKAKAV |
| O00232 | S335 | Sugiyama | PSMD12 | MRWSTLVEDYGMELRKGsLEsPAtDVFGsTEEGEKRWKDLK |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00418 | S377 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EEF2K | CGsPQVRTLsGSRPPLLRPLsENSGDENMSDVTFDsLPSsP |
| O14497 | S363 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | AAAAAAASGGAQQRsHHAPMsPGssGGGGQPLARtPQPssP |
| O14545 | T323 | Sugiyama | TRAFD1 FLN29 | ELLIDHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQ |
| O14639 | S452 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | PtPsAEGyQDVRDRMIHRstsQGsINsPVySRHsYtPTTSR |
| O14745 | S280 | Sugiyama | NHERF1 NHERF SLC9A3R1 | tNGEIQKENsREALAEAALEsPRPALVRsAssDtsEELNsQ |
| O14745 | S291 | Sugiyama | NHERF1 NHERF SLC9A3R1 | EALAEAALEsPRPALVRsAssDtsEELNsQDsPPKQDSTAP |
| O14910 | S130 | Sugiyama | LIN7A MALS1 VELI1 | ELPKTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLK |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | S995 | Sugiyama | PPP1R12A MBS MYPT1 | ADRSLLEMEKRERRALERRIsEMEEELKMLPDLKADNQRLK |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15226 | S618 | Sugiyama | NKRF ITBA4 NRF | VNKIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQ |
| O15511 | S77 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | ARPC5 ARC16 | AALKNPPINTKSQAVKDRAGsIVLKVLISFKANDIEKAVQS |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O43865 | S66 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | DDMQEFTKFPTKTGRRSLSRsIsQSsTDsySsAASYTDssD |
| O60333 | S649 | Sugiyama | KIF1B KIAA0591 KIAA1448 | NHVFRFNHPEQARAEREKtPsAEtPsEPVDWTFAQRELLEK |
| O60333 | T652 | Sugiyama | KIF1B KIAA0591 KIAA1448 | FRFNHPEQARAEREKtPsAEtPsEPVDWTFAQRELLEKQGI |
| O60343 | S485 | Sugiyama | TBC1D4 AS160 KIAA0603 | CERIEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPV |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60664 | S148 | Sugiyama | PLIN3 M6PRBP1 TIP47 | KVsGAQEMVssAKDTVAtQLsEAVDATRGAVQSGVDKTKsV |
| O60749 | S365 | Sugiyama | SNX2 TRG9 | AKSAAMLGNsEDHTALSRALsQLAEVEEKIDQLHQEQAFAD |
| O75179 | S2042 | Sugiyama | ANKRD17 GTAR KIAA0697 | TAPTNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLD |
| O75179 | S2045 | Sugiyama | ANKRD17 GTAR KIAA0697 | TNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLDCGs |
| O75391 | S158 | Sugiyama | SPAG7 | LKELAQRQEEEAAQQGPVVVsPAsDyKDKYSHLIGKGAAKD |
| O75534 | S584 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | YSLSKGKGNKVSAEKVNKtHsVNGItEEADPTIysGKVIRP |
| O75925 | S522 | SIGNOR|EPSD|PSP | PIAS1 DDXBP1 | AsPVsRtPsLPAVDtsYINTsLIQDYRHPFHMTPMPYDLQG |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95155 | S79 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | NMtPAtsPIGASGVAHRsQssEGVssLsssPsNsLEtQsQs |
| O95197 | T318 | Sugiyama | RTN3 ASYIP NSPL2 | RNKEAGRYPMSALLSRQFsHtNAALEEVSRCVNDMHNFTNE |
| O95359 | S2317 | Sugiyama | TACC2 | MPLRRPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTF |
| O95359 | S2321 | Sugiyama | TACC2 | RPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTFDIDK |
| O95425 | S221 | Sugiyama | SVIL | NIENQRRGQELsATRQAHDLsPAAEsssTFsFSGRDssFtE |
| O95453 | S557 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | PARN DAN | KRLNPQCIPYTLQNHYYRNNsFtAPstVGKRNLsPsQEEAG |
| O95816 | S20 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BAG2 | _MAQAKINAKANEGRFCRsssMADRsSRLLEsLDQLELRVE |
| P00367 | T409 | Sugiyama | GLUD1 GLUD | TKSNAPRVKAKIIAEGANGPttPEADKIFLERNIMVIPDLY |
| P00367 | T410 | Sugiyama | GLUD1 GLUD | KSNAPRVKAKIIAEGANGPttPEADKIFLERNIMVIPDLYL |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P03372 | S118 | EPSD | ESR1 ESR NR3A1 | PPLNsVsPsPLMLLHPPPQLsPFLQPHGQQVPYYLENEPSG |
| P04075 | S176 | Sugiyama | ALDOA ALDA | EHtPsALAIMENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04637 | S20 | EPSD|PSP | TP53 P53 | _MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQAM |
| P04792 | S15 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | HSPB1 HSP27 HSP28 | ______MTERRVPFsLLRGPsWDPFRDWyPHsRLFDQAFGL |
| P04792 | S78 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05023 | S519 | Sugiyama | ATP1A1 | sEPQHLLVMKGAPERILDRCssILLHGKEQPLDEELKDAFQ |
| P05023 | S520 | Sugiyama | ATP1A1 | EPQHLLVMKGAPERILDRCssILLHGKEQPLDEELKDAFQN |
| P05387 | S86 | Sugiyama | RPLP2 D11S2243E RPP2 | PAGGAVAVsAAPGsAAPAAGsAPAAAEEKKDEKKEEsEEsD |
| P05455 | S92 | Sugiyama | SSB | LSKSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRs |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05783 | S53 | EPSD|PSP | KRT18 CYK18 PIG46 | AsVyAGAGGsGsRIsVsRstsFRGGMGsGGLAtGIAGGLAG |
| P05997 | S1277 | Sugiyama | COL5A2 | APDDKNKTDPGVHATLKSLSsQIETMRSPDGSKKHPARTCD |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P07101 | S19 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TH TYH | __MPTPDATTPQAKGFRRAVsELDAKQAEAIMVRGQGAPGP |
| P07101 | S40 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | TH TYH | ELDAKQAEAIMVRGQGAPGPsLTGsPWPGTAAPAASYTPTP |
| P07101 | S71 | EPSD|PSP | TH TYH | APAASYTPTPRsPRFIGRRQsLIEDARKEREAAVAAAAAAV |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08670 | S39 | GPS6|ELM|iPTMNet|EPSD | VIM | GtAsRPsssRsYVttsTRtYsLGsALRPstsRsLyAssPGG |
| P08670 | S51 | GPS6|ELM|iPTMNet|EPSD | VIM | VttsTRtYsLGsALRPstsRsLyAssPGGVyAtRssAVRLR |
| P08670 | S56 | GPS6|ELM|iPTMNet|EPSD | VIM | RtYsLGsALRPstsRsLyAssPGGVyAtRssAVRLRssVPG |
| P08670 | S83 | GPS6|ELM|iPTMNet|EPSD | VIM | tRssAVRLRssVPGVRLLQDsVDFsLADAINTEFKNTRTNE |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09917 | S272 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ALOX5 LOG5 | LPEKLPVtTEMVECSLERQLsLEQEVQQGNIFIVDFELLDG |
| P09972 | S176 | Sugiyama | ALDOC ALDC | ERTPSALAILENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P0DPH7 | S54 | Sugiyama | TUBA3C TUBA2 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P10809 | T117 | Sugiyama | HSPD1 HSP60 | LVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISKGANP |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11388 | S1247 | Sugiyama | TOP2A TOP2 | MKAEAEKKNKKKIKNENtEGsPQEDGVELEGLKQRLEKKQK |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P11532 | S3624 | Sugiyama | DMD | AKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEED |
| P11831 | S103 | SIGNOR|iPTMNet|EPSD|PSP | SRF | sEsGEEEELGAERRGLKRsLsEMEIGMVVGGPEASAAATGG |
| P11831 | S85 | GPS6|ELM|iPTMNet|EPSD | SRF | ATTPAPTAGALYsGsEGDsEsGEEEELGAERRGLKRsLsEM |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P12277 | T35 | Sugiyama | CKB CKBB | PAEDEFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDD |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13797 | S339 | Sugiyama | PLS3 | PRIDINMsGFNETDDLKRAEsMLQQADKLGCRQFVTPADVV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15336 | S62 | Sugiyama | ATF2 CREB2 CREBP1 | LAVHKHKHEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEV |
| P15336 | T69 | Sugiyama | ATF2 CREB2 CREBP1 | HEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELA |
| P15336 | T71 | Sugiyama | ATF2 CREB2 CREBP1 | MtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELAsP |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P16220 | S119 | SIGNOR|PSP | CREB1 | EsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVPRIEE |
| P16949 | S38 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17302 | S255 | PSP | GJA1 GJAL | GVKDRVKGKSDPyHATsGALsPAKDCGsQKyAyFNGCssPt |
| P17302 | S279 | PSP | GJA1 GJAL | DCGsQKyAyFNGCssPtAPLsPMsPPGyKLVTGDRNNssCR |
| P17302 | S282 | PSP | GJA1 GJAL | sQKyAyFNGCssPtAPLsPMsPPGyKLVTGDRNNssCRNYN |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17544 | T42 | Sugiyama | ATF7 ATFA | DHLAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCE |
| P17544 | T51 | Sugiyama | ATF7 ATFA | HEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELA |
| P17544 | T53 | Sugiyama | ATF7 ATFA | MTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELASS |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17844 | S198 | EPSD|PSP | DDX5 G17P1 HELR HLR1 | ELAQQVQQVAAEyCRACRLKsTCIyGGAPKGPQIRDLERGV |
| P18615 | S115 | EPSD|PSP|Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18615 | S138 | Sugiyama | NELFE RD RDBP | DDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEGPGA |
| P18615 | S251 | EPSD|PSP | NELFE RD RDBP | DRDRERDRDRDREGPFRRsDsFPERRAPRKGNTLyVyGEDM |
| P18615 | S51 | EPSD|PSP | NELFE RD RDBP | ALKKQSSSSTTSQGGVKRsLsEQPVMDTATATEQAKQLVKS |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18859 | S57 | Sugiyama | ATP5PF ATP5A ATP5J ATPM | DPIQKLFVDKIREYKSKRQTsGGPVDAssEyQQELERELFK |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P21333 | S2319 | Sugiyama | FLNA FLN FLN1 | VQEPGDyEVsVKFNEEHIPDsPFVVPVAsPsGDARRLtVss |
| P21333 | S2327 | Sugiyama | FLNA FLN FLN1 | VsVKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKV |
| P21333 | S2329 | Sugiyama | FLNA FLN FLN1 | VKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKVNQ |
| P22059 | S240 | Sugiyama | OSBP OSBP1 | DLSTCNDLIAKHGTALQRsLsELEsLKLPAESNEKIKQVNE |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P23396 | T221 | Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25054 | S2129 | Sugiyama | APC DP2.5 | NSIVSSLHQAAAAACLsRQAssDSDSILSLKsGIsLGsPFH |
| P25786 | S110 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | QECLDSRFVFDRPLPVsRLVsLIGsKTQIPTQRYGRRPYGV |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26447 | S60 | Sugiyama | S100A4 CAPL MTS1 | RELPSFLGKRTDEAAFQKLMsNLDSNRDNEVDFQEYCVFLS |
| P26651 | S113 | SIGNOR | ZFP36 G0S24 NUP475 RNF162A TIS11A TTP | sPtATSTtPSRYKTELCRTFsESGRCRYGAKCQFAHGLGEL |
| P26651 | S184 | SIGNOR | ZFP36 G0S24 NUP475 RNF162A TIS11A TTP | FIHNPSEDLAAPGHPPVLRQsIsFsGLPSGRRTsPPPPGLA |
| P26651 | S186 | GPS6|SIGNOR|EPSD | ZFP36 G0S24 NUP475 RNF162A TIS11A TTP | HNPSEDLAAPGHPPVLRQsIsFsGLPSGRRTsPPPPGLAGP |
| P26651 | S52 | EPSD | ZFP36 G0S24 NUP475 RNF162A TIS11A TTP | WGSSGPWSLSPSDSSPSGVTsRLPGRSTsLVEGRsCGWVPP |
| P26651 | S60 | GPS6|SIGNOR|EPSD | ZFP36 G0S24 NUP475 RNF162A TIS11A TTP | LSPSDSSPSGVTsRLPGRSTsLVEGRsCGWVPPPPGFAPLA |
| P26651 | S66 | SIGNOR | ZFP36 G0S24 NUP475 RNF162A TIS11A TTP | SPSGVTsRLPGRSTsLVEGRsCGWVPPPPGFAPLAPRLGPE |
| P27348 | S63 | Sugiyama | YWHAQ | LLsVAyKNVVGGRRSAWRVIsSIEQKTDTSDKKLQLIKDYR |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27815 | S152 | SIGNOR | PDE4A DPDE2 | VLHAGAATSQRREsFLYRSDsDYDMsPKTMSRNssVtsEAH |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29966 | S27 | Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P30305 | S169 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | FQsMPVRLLGHsPVLRNItNsQAPDGRRKsEAGSGAAssSG |
| P30305 | S323 | GPS6|ELM|iPTMNet|EPSD|PSP | CDC25B CDC25HU2 | KEEEKDLVMYSKCQRLFRsPsMPCSVIRPILKRLERPQDRD |
| P30305 | S353 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | LKRLERPQDRDTPVQNKRRRsVtPPEEQQEAEEPKARVLRs |
| P30305 | S375 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | tPPEEQQEAEEPKARVLRsKsLCHDEIENLLDSDHRELIGD |
| P30307 | S216 | EPSD|PSP | CDC25C | EFsLKDQEAKVSRsGLYRsPsMPENLNRPRLKQVEKFKDNt |
| P31749 | S473 | EPSD|PSP | AKT1 PKB RAC | DQDDSMECVDSERRPHFPQFsysAsGtA_____________ |
| P31943 | S23 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | LGTEGGEGFVVKVRGLPWsCsADEVQRFFSDCKIQNGAQGI |
| P31946 | S132 | Sugiyama | YWHAB | TQPESKVFyLKMKGDYFRyLsEVAsGDNKQTtVsNsQQAyQ |
| P31946 | S65 | Sugiyama | YWHAB | LLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQMGKEYR |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P33241 | S204 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | LSP1 WP34 | tIEQssPPLsPttKLIDRtEsLNRsIEKSNSVKKsQPDLPI |
| P33241 | S252 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | LSP1 WP34 | EQyTQAIETAGRTPKLARQAsIELPSMAVASTKSRWETGEV |
| P33527 | S915 | Sugiyama | ABCC1 MRP MRP1 | QMENGMLVTDsAGKQLQRQLsssssysGDISRHHNstAELQ |
| P34931 | S241 | SIGNOR|PSP | HSPA1L | VKAtAGDtHLGGEDFDNRLVsHFVEEFKRKHKKDISQNKRA |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35900 | S13 | GPS6|SIGNOR|EPSD|PSP | KRT20 | ________MDFSRRSFHRSLsSSLQAPVVSTVGMQRLGTTP |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P40189 | S782 | GPS6 | IL6ST | VVHSGyRHQVPSVQVFSRsEstQPLLDSEERPEDLQLVDHV |
| P40222 | S514 | Sugiyama | TXLNA TXLN | GsLtDsGPERRPEGPGAQAPssPRVtEAPCyPGAPSTEASG |
| P40337 | S68 | Sugiyama | VHL | LGAEEEMEAGRPRPVLRSVNsREPsQVIFCNRsPRVVLPVW |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43686 | S117 | Sugiyama | PSMC4 MIP224 TBP7 | DQNTAIVGSTTGSNYYVRILsTIDRELLKPNASVALHKHSN |
| P46013 | S308 | Sugiyama | MKI67 | VSRKSRPKsGGsGHAVAEPAsPEQELDQNKGKGRDVEsVQt |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P46937 | T110 | Sugiyama | YAP1 YAP65 | KLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssPA |
| P46937 | T119 | Sugiyama | YAP1 YAP65 | PEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQLGAVsP |
| P47756 | S207 | Sugiyama | CAPZB | MNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKIRst |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49137 | S339 | Sugiyama | MAPKAPK2 | FMNHPWIMQSTKVPQtPLHtsRVLKEDKERWEDVKEEMtsA |
| P49137 | S358 | Sugiyama | MAPKAPK2 | tsRVLKEDKERWEDVKEEMtsALATMRVDYEQIKIKKIEDA |
| P49137 | T195 | Sugiyama | MAPKAPK2 | QYLHSINIAHRDVKPENLLYtSKRPNAILKLtDFGFAKEtt |
| P49137 | T226 | Sugiyama | MAPKAPK2 | tDFGFAKEttsHNsLttPCytPyyVAPEVLGPEKYDKSCDM |
| P49137 | T334 | Sugiyama | MAPKAPK2 | MTItEFMNHPWIMQSTKVPQtPLHtsRVLKEDKERWEDVKE |
| P49137 | T338 | GPS6|ELM|iPTMNet|EPSD|PSP|Sugiyama | MAPKAPK2 | EFMNHPWIMQSTKVPQtPLHtsRVLKEDKERWEDVKEEMts |
| P49137 | T357 | Sugiyama | MAPKAPK2 | HtsRVLKEDKERWEDVKEEMtsALATMRVDYEQIKIKKIED |
| P49137 | Y225 | Sugiyama | MAPKAPK2 | LtDFGFAKEttsHNsLttPCytPyyVAPEVLGPEKYDKSCD |
| P49137 | Y228 | Sugiyama | MAPKAPK2 | FGFAKEttsHNsLttPCytPyyVAPEVLGPEKYDKSCDMWS |
| P49137 | Y229 | Sugiyama | MAPKAPK2 | GFAKEttsHNsLttPCytPyyVAPEVLGPEKYDKSCDMWSL |
| P49448 | T409 | Sugiyama | GLUD2 GLUDP1 | TKSNAPRVKAKIIAEGANGPttPEADKIFLERNILVIPDLY |
| P49448 | T410 | Sugiyama | GLUD2 GLUDP1 | KSNAPRVKAKIIAEGANGPttPEADKIFLERNILVIPDLYL |
| P49588 | S249 | Sugiyama | AARS1 AARS | ILKPLPKKsIDtGMGLERLVsVLQNKMSNYDTDLFVPYFEA |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P49815 | S1254 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TSC2 TSC4 | ALMAAERFKEHRDTALYKsLsVPAAsTAKPPPLPRSNTVAS |
| P50502 | S181 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | LQKPNAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| P50549 | S191 | SIGNOR|iPTMNet|EPSD | ETV1 ER81 | PSQSIPDSSYPMDHRFRRQLsEPCNSFPPLPTMPREGRPMY |
| P50549 | S216 | SIGNOR|iPTMNet|EPSD | ETV1 ER81 | SFPPLPTMPREGRPMYQRQMsEPNIPFPPQGFKQEYHDPVY |
| P50552 | T335 | Sugiyama | VASP | tTLPRMKssssVttsEtQPCtPsSSDySDLQRVKQELLEEV |
| P50991 | S444 | Sugiyama | CCT4 CCTD SRB | GGGAPEIELALRLTEYSRTLsGMEsyCVRAFADAMEVIPST |
| P51812 | S386 | GPS6|EPSD | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | PKDsPGIPPsANAHQLFRGFsFVAItsDDESQAMQTVGVHS |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52948 | S623 | Sugiyama | NUP98 ADAR2 | KNLNNsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDE |
| P53350 | S326 | SIGNOR|EPSD|PSP | PLK1 PLK | TSGYIPARLPITCLTIPPRFsIAPssLDPsNRKPLtVLNKG |
| P53350 | S383 | EPSD|PSP | PLK1 PLK | VRETGEVVDCHLsDMLQQLHsVNAsKPSERGLVRQEEAEDP |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53667 | S323 | GPS6|SIGNOR|EPSD|PSP | LIMK1 LIMK | PGAGsLGsPAsQRKDLGRSEsLRVVCRPHRIFRPSDLIHGE |
| P53992 | S378 | Sugiyama | SEC24C KIAA0079 | TTNFLVKDQGNASPRYIRCTsyNIPCTSDMAKQAQVPLAAV |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P55010 | S10 | Sugiyama | EIF5 | ___________MSVNVNRsVsDQFyRyKMPRLIAKVEGKGN |
| P55036 | S115 | Sugiyama | PSMD4 MCB1 | LALKHRQGKNHKMRIIAFVGsPVEDNEKDLVKLAKRLKKEK |
| P55196 | S1698 | Sugiyama | AFDN AF6 MLLT4 | PEAPGLCRPPLPRDyEPPsPsPAPGAPPPPPQRNASYLKtQ |
| P55196 | S424 | Sugiyama | AFDN AF6 MLLT4 | HTYEDGSDSRDKPKLYRLQLsVtEVGTEKLDDNSIQLFGPG |
| P57772 | S28 | Sugiyama | EEFSEC SELB | VNVGVLGHIDSGKTALARALsTTASTAAFDKQPQSRERGIT |
| P60174 | Y48 | Sugiyama | TPI1 TPI | tLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQNCy |
| P60228 | S442 | Sugiyama | EIF3E EIF3S6 INT6 | IEKKLNQNSRSEAPNWAtQDsGFy_________________ |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61758 | T45 | Sugiyama | VBP1 PFDN3 | IPEAVFVEDVDSFMKQPGNEtADtVLKKLDEQYQKYKFMEL |
| P61978 | S77 | Sugiyama | HNRNPK HNRPK | VIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIETI |
| P61981 | S64 | Sugiyama | YWHAG | LLsVAyKNVVGARRSsWRVIsSIEQKtsADGNEKKIEMVRA |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P63010 | S531 | Sugiyama | AP2B1 ADTB2 CLAPB1 | TQDSDNPDLRDRGyIyWRLLsTDPVTAKEVVLSEKPLISEE |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S58 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | YWHAZ | NEERNLLsVAyKNVVGARRssWRVVssIEQKTEGAEKKQQM |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P68363 | S54 | Sugiyama | TUBA1B | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| P98082 | S723 | Sugiyama | DAB2 DOC2 | DANQLLNKINEPPKPAPRQVsLPVTKstDNAFENPFFKDsF |
| Q00610 | S146 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AVYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLL |
| Q00613 | S121 | GPS6|ELM|iPTMNet|EPSD|PSP | HSF1 HSTF1 | HPCFLRGQEQLLENIKRKVtsVSTLKSEDIKIRQDSVTKLL |
| Q00987 | S157 | EPSD|PSP | MDM2 | DLVQELQEEKPSSSHLVSRPstSSRRRAIsEtEENsDELsG |
| Q00987 | S166 | SIGNOR|EPSD|PSP | MDM2 | KPSSSHLVSRPstSSRRRAIsEtEENsDELsGERQRKRHKs |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01814 | S1234 | Sugiyama | ATP2B2 PMCA2 | DSGINLTTDtsKSATSSsPGsPIHSLEtsL___________ |
| Q01844 | T422 | Sugiyama | EWSR1 EWS | LDKETGKPKGDATVSyEDPPtAKAAVEWFDGKDFQGSKLKV |
| Q01860 | S111 | GPS6|PSP | POU5F1 OCT3 OCT4 OTF3 | ETsQPEGEAGVGVESNSDGAsPEPCTVtPGAVKLEKEKLEQ |
| Q01860 | S93 | PSP | POU5F1 OCT3 OCT4 OTF3 | MAYCGPQVGVGLVPQGGLETsQPEGEAGVGVESNSDGAsPE |
| Q02952 | T285 | Sugiyama | AKAP12 AKAP250 | CKEEGEEKQEKEPSKsAEsPtsPVtsETGstFKKFFTQGWA |
| Q04637 | S1231 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | tEDRDRGRDAVKREAALPPVsPLKAALsEEELEKKsKAIIE |
| Q04721 | S838 | Sugiyama | NOTCH2 | TCHCVLPYTGKNCQTVLAPCsPNPCENAAVCKESPNFESYT |
| Q04917 | S64 | Sugiyama | YWHAH YWHA1 | LLsVAyKNVVGARRSsWRVIsSIEQKTMADGNEKKLEKVKA |
| Q05397 | S677 | Sugiyama | PTK2 FAK FAK1 | KCWAYDPSRRPRFTELKAQLsTILEEEKAQQEERMRMEsRR |
| Q06124 | S140 | Sugiyama | PTPN11 PTP2C SHPTP2 | KEAEKLLTEKGKHGsFLVREsQsHPGDFVLSVRTGDDKGES |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q06830 | T156 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | KGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEVCPAG |
| Q07352 | S203 | GPS6|SIGNOR|EPSD|PSP | ZFP36L1 BERG36 BRF1 ERF1 RNF162B TIS11B | RALAGARDLSADRPRLQHSFsFAGFPSAAATAAATGLLDSP |
| Q07352 | S54 | GPS6|SIGNOR|EPSD|PSP | ZFP36L1 BERG36 BRF1 ERF1 RNF162B TIS11B | CLLDRKAVGtPAGGGFPRRHsVTLPSSKFHQNQLLSsLKGE |
| Q07352 | S92 | GPS6|SIGNOR|EPSD|PSP | ZFP36L1 BERG36 BRF1 ERF1 RNF162B TIS11B | KGEPAPALSSRDsRFRDRsFsEGGERLLPTQKQPGGGQVNS |
| Q07817 | S62 | EPSD|PSP | BCL2L1 BCL2L BCLX | ESEMEtPsAINGNPSWHLADsPAVNGATGHSSSLDAREVIP |
| Q07866 | S460 | Sugiyama | KLC1 KLC KNS2 | QKDGTsFGEyGGWyKACKVDsPtVTTtLKNLGALyRRQGKF |
| Q07960 | S51 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | KNWPsDEMPDFPKsDDsKsssPELVtHLKWDDPyyDIARHQ |
| Q08AD1 | S1313 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | sLNtGDNEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWE |
| Q08AD1 | S464 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | FDKEDSVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLS |
| Q08J23 | S743 | Sugiyama | NSUN2 SAKI TRM4 | AstGQPDNDVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGV |
| Q08J23 | S751 | Sugiyama | NSUN2 SAKI TRM4 | DVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGVHPPR____ |
| Q09666 | S41 | Sugiyama | AHNAK PM227 | HGLTIAQRDDGVFVQEVtQNsPAARTGVVKEGDQIVGATIy |
| Q09666 | T3716 | Sugiyama | AHNAK PM227 | VEGDLKGPEVDIKGPKVDIDtPDINIEGsEGKFKGPKFKIP |
| Q10567 | S531 | Sugiyama | AP1B1 ADTB1 BAM22 CLAPB2 | TQDSDNPDLRDRGyIyWRLLsTDPVAAKEVVLAEKPLISEE |
| Q12931 | S568 | Sugiyama | TRAP1 HSP75 HSPC5 | ISVETDIVVDHYKEEKFEDRsPAAECLSEKETEELMAWMRN |
| Q12965 | S1002 | Sugiyama | MYO1E MYO1C | RSNQKSLyTsMARPPLPRQQstssDRVsQtPEsLDFLKVPD |
| Q13137 | S238 | Sugiyama | CALCOCO2 NDP52 | KMSSENEKMGIRVDQLQAQLsTQEKEMEKLVQGDQDKTEQL |
| Q13151 | S84 | GPS6|SIGNOR|EPSD|PSP | HNRNPA0 HNRPA0 | AMAAsPHAVDGNTVELKRAVsREDsARPGAHAKVKKLFVGG |
| Q13206 | S829 | Sugiyama | DDX10 | sEDMENKISDTKKKQGMKKRsNsEVEDVGPTsHNRKKARWD |
| Q13206 | S831 | Sugiyama | DDX10 | DMENKISDTKKKQGMKKRsNsEVEDVGPTsHNRKKARWDTL |
| Q13263 | S473 | EPSD|PSP|Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13464 | S742 | Sugiyama | ROCK1 | EEREAREKAENRVVQIEKQCsMLDVDLKQSQQKLEHLTGNK |
| Q13546 | S320 | EPSD|PSP | RIPK1 RIP RIP1 | DVKSLKKEYSNENAVVKRMQsLQLDCVAVPssRsNsAtEQP |
| Q13573 | S224 | Sugiyama | SNW1 SKIIP SKIP | KDPMEPPRFKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQE |
| Q13596 | S368 | Sugiyama | SNX1 | AKSLAMLGSSEDNTALSRALsQLAEVEEKIEQLHQEQANND |
| Q14103 | S190 | Sugiyama | HNRNPD AUF1 HNRPD | KRAKAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVES |
| Q14103 | T193 | Sugiyama | HNRNPD AUF1 HNRPD | KAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVESIEL |
| Q14126 | S551 | Sugiyama | DSG2 CDHF5 | FSVIDKPPGMAEKWKIARQEstsVLLQQSEKKLGRSEIQFL |
| Q14126 | S553 | Sugiyama | DSG2 CDHF5 | VIDKPPGMAEKWKIARQEstsVLLQQSEKKLGRSEIQFLIS |
| Q14126 | T552 | Sugiyama | DSG2 CDHF5 | SVIDKPPGMAEKWKIARQEstsVLLQQSEKKLGRSEIQFLI |
| Q14134 | S550 | SIGNOR|EPSD|PSP | TRIM29 ATDC | LPVVQGSSSFsLKGyPSLMRsQsPKAQPQTWKSGKQTMLSH |
| Q14134 | S552 | EPSD|PSP | TRIM29 ATDC | VVQGSSSFsLKGyPSLMRsQsPKAQPQTWKSGKQTMLSHYR |
| Q14160 | S504 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | MKRSIEGRRsEACPCQPDsGsPLPAEEEKRLsAESGLSEDS |
| Q14204 | S4162 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GRIFVFEPPPGVKANMLRTFssIPVSRICKSPNERARLYFL |
| Q14247 | S282 | Sugiyama | CTTN EMS1 | QKDyKTGFGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDy |
| Q14247 | S405 | Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14457 | S90 | EPSD|PSP | BECN1 GT197 | IETPRQDGVSRRFIPPARMMsTEsANsFTLIGEASDGGtME |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14676 | T447 | Sugiyama | MDC1 KIAA0170 NFBD1 | WNRDAEEDMPQRVVLLQRsQtttERDsDtDVEEEELPVENR |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q15003 | S78 | Sugiyama | NCAPH BRRN BRRN1 CAPH KIAA0074 | NDDEKERLQRRRsRVFDLQFstDsPRLLAsPsSRsIDIsAT |
| Q15084 | S389 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | FALLKGsFsEQGINEFLRELsFGRGstAPVGGGAFPtIVER |
| Q15181 | S272 | Sugiyama | PPA1 IOPPP PP | FKCDPDAARAIVDALPPPCEsACTVPTDVDKWFHHQKN___ |
| Q15276 | S407 | Sugiyama | RABEP1 RAB5EP RABPT5 RABPT5A | GDPFSKSDNDMFKDGLRRAQstDsLGtsGsLQSKALGYNYK |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15365 | S190 | Sugiyama | PCBP1 | LsQsPQGRVMtIPyQPMPAssPVICAGGQDRCsDAAGYPHA |
| Q15599 | S43 | Sugiyama | NHERF2 SLC9A3R2 | FHLHGEKGRRGQFIRRVEPGsPAEAAALRAGDRLVEVNGVN |
| Q15759 | S243 | Sugiyama | MAPK11 PRKM11 SAPK2 SAPK2B | FPGSDYIDQLKRIMEVVGtPsPEVLAKISSEHARTYIQsLP |
| Q15759 | T180 | Sugiyama | MAPK11 PRKM11 SAPK2 SAPK2B | EDCELRILDFGLARQADEEMtGyVAtRWYRAPEIMLNWMHY |
| Q15759 | T241 | Sugiyama | MAPK11 PRKM11 SAPK2 SAPK2B | ALFPGSDYIDQLKRIMEVVGtPsPEVLAKISSEHARTYIQs |
| Q15759 | Y182 | Sugiyama | MAPK11 PRKM11 SAPK2 SAPK2B | CELRILDFGLARQADEEMtGyVAtRWYRAPEIMLNWMHYNQ |
| Q15785 | S45 | Sugiyama | TOMM34 URCC3 | yAEASALyGRALRVLQAQGssDPEEEsVLysNRAACHLKDG |
| Q15788 | S1185 | EPSD | NCOA1 BHLHE74 SRC1 | QQFPYPPNYGTNPGtPPASTsPFSQLAANPEASLANRNSMV |
| Q15788 | T1179 | EPSD | NCOA1 BHLHE74 SRC1 | LPQGAPQQFPYPPNYGTNPGtPPASTsPFSQLAANPEASLA |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16204 | S323 | Sugiyama | CCDC6 D10S170 TST1 | RLQRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQ |
| Q16630 | T157 | Sugiyama | CPSF6 CFIM68 | SKKLMDLLPKRELHGQNPVVtPCNKQFLsQFEMQSRKTTQS |
| Q16644 | S337 | Sugiyama | MAPKAPK3 | tARVLQEDKDHWDEVKEEMTsALATMRVDYDQVKIKDLKTS |
| Q16644 | T175 | Sugiyama | MAPKAPK3 | QFLHSHNIAHRDVKPENLLYtSKEKDAVLKLTDFGFAKEtt |
| Q16875 | S461 | EPSD|PSP | PFKFB3 | THRERSEDAKKGPNPLMRRNsVtPLAsPEPtKKPRINsFEE |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3MII6 | S506 | Sugiyama | TBC1D25 OATL1 | DHLATASQGPGGGGRLLRQAsLDGLQQLRDNMGSRRDPLVQ |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q5JTD0 | S545 | Sugiyama | TJAP1 PILT TJP4 | ssRPQRsPKRMGVHHLHRKDsLtQAQEQGNLLN________ |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q5T4S7 | S181 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | PQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLTSVF |
| Q66K14 | S1238 | Sugiyama | TBC1D9B KIAA0676 | EKRVDIGLKIKDQKKVERQFstAsDHEQPGVsG________ |
| Q6JBY9 | S179 | GPS6|SIGNOR|EPSD|PSP | RCSD1 CAPZIP | VRTRGSIKRRPPSRRFRRsQsDCGELGDFRAVESSQQNGAK |
| Q6JBY9 | S244 | GPS6|SIGNOR|EPSD|PSP | RCSD1 CAPZIP | AGEGVRTLGPAEKPPLRRSPsRTEKQEEDRATEEAKNGEKA |
| Q6PEY2 | S54 | Sugiyama | TUBA3E | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6UVK1 | S1857 | Sugiyama | CSPG4 MCSP | ASVPLRLTRGSRAPISRAQLsVVDPDSAPGEIEyEVQRAPH |
| Q71U36 | S54 | Sugiyama | TUBA1A TUBA3 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7L2J0 | S216 | Sugiyama | MEPCE BCDIN3 | NLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDIt |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7L5N7 | S34 | SIGNOR | LPCAT2 AGPAT11 AYTL1 | VPGAGVGNVGLRPPMVPRQAsFFPPPVPNPFVQQTQIGSAR |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q86YP4 | S100 | Sugiyama | GATAD2A | DGPVDMRTSHSDMKSERRPPsPDVIVLsDNEQPssPRVNGL |
| Q86YP4 | S114 | Sugiyama | GATAD2A | SERRPPsPDVIVLsDNEQPssPRVNGLttVALKETSTEALM |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8IZ21 | S590 | Sugiyama | PHACTR4 PRO2963 | SKEEWNEIRHQIGNTLIRRLsQRPtPEELEQRNILQPKNEA |
| Q8N556 | S264 | Sugiyama | AFAP1 AFAP | IKEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssD |
| Q8N556 | S668 | Sugiyama | AFAP1 AFAP | AGGVTLGLAIEPKsGtssPQsPVFRHRtLENsPIssCDtsD |
| Q8N5C8 | S506 | GPS6|EPSD|PSP | TAB3 MAP3K7IP3 | ISVIPGsGGEKGSHKYQRssssGsDDyAyTQALLLHQRARM |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBJ7 | S281 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | ADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL |
| Q8ND56 | S300 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | GRFGIRRDGPMKFEKDFDFEsANAQFNKEEIDREFHNKLKL |
| Q8NFH8 | S631 | Sugiyama | REPS2 POB1 | AIQTAIRKNKEANAVLARLNsELQQQLKEVHQERIALENQL |
| Q8NFI4 | S181 | Sugiyama | ST13P5 FAM10A5 | LQKPNAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| Q8NI08 | S208 | Sugiyama | NCOA7 ERAP140 ESNA1 Nbla00052 Nbla10993 | DKLPDADLARKALKPIERVLsstsEEDEPGVVKFLKMNCRY |
| Q8TC07 | S675 | Sugiyama | TBC1D15 | TSAFQSNALPTLSASGARNDsPtQIPVssDVCRLtPA____ |
| Q8WX93 | S479 | Sugiyama | PALLD KIAA0992 CGI-151 | VLECRVRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAE |
| Q8WXH0 | S2781 | Sugiyama | SYNE2 KIAA1011 NUA | ILSQIRKCKVTHDGILARQQsVEsLAEEVKDKVPSLTTYEG |
| Q92530 | S153 | Sugiyama | PSMF1 | RIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIPP |
| Q92530 | T162 | Sugiyama | PSMF1 | IHEQWEKANVssPHREFPPAtAREVDPLRIPPHHPHTSRQP |
| Q92904 | S65 | EPSD|PSP | DAZL DAZH DAZL1 DAZLA SPGYLA | GGIDVRMDETEIRSFFARYGsVKEVKIITDRTGVSKGYGFV |
| Q92905 | S177 | PSP | COPS5 CSN5 JAB1 | LNQQFQEPFVAVVIDPTRTIsAGKVNLGAFRTYPKGYKPPD |
| Q92945 | S181 | Sugiyama | KHSRP FUBP2 | GRGGEQINKIQQDSGCKVQIsPDsGGLPERsVsLtGAPEsV |
| Q969V6 | S312 | EPSD|PSP | MRTFA KIAA1438 MAL MKL1 | PPKSAGEALGSsGtPPVRsLsttNSSSSsGAPGPCGLARQN |
| Q969V6 | S333 | EPSD|PSP | MRTFA KIAA1438 MAL MKL1 | ttNSSSSsGAPGPCGLARQNstsLtGKPGALPANLDDMKVA |
| Q96AE4 | S630 | Sugiyama | FUBP1 | DYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ______ |
| Q96AE4 | Y626 | Sugiyama | FUBP1 | GGQPDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ__ |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96BY7 | S497 | Sugiyama | ATG2B C14orf103 | PSNLVHPTPLQKtsLPsRsVsVDESRPELIFRLAVGTFSIS |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96D71 | S767 | Sugiyama | REPS1 | AIQAsIRRNKETNTVLARLNsELQQQLKDVLEERISLEVQL |
| Q96E11 | S239 | Sugiyama | MRRF | LKKSKDTVsEDtIRLIEKQIsQMADDtVAELDRHLAVKTKE |
| Q96FS4 | S55 | Sugiyama | SIPA1 SPA1 | PLTPHTFEPRPVRGPLLRsGsDAGEARPPtPAsPRARAHsH |
| Q96HE7 | S173 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | LQWTKHDDSSDNFCEADDIQsPEAEyVDLLLNPERYTGYKG |
| Q96IR7 | S360 | Sugiyama | HPDL GLOXD1 | LIQRQGATGFGQGNIRALWQsVQEQsARSQEA_________ |
| Q96J92 | S575 | EPSD|PSP | WNK4 PRKWNK4 | PPEPEEPEADQHQPFLFRHAsYSSTTSDCETDGYLSSSGFL |
| Q96N67 | S1432 | Sugiyama | DOCK7 KIAA1771 | RRSRGQLGTYTIAsPPERsPsGsAFGsQENLRWRKDMTHWR |
| Q96P16 | S109 | Sugiyama | RPRD1A P15RS | FKHVSSETDESCKKHLGRVLsIWEERSVYENDVLEQLKQAL |
| Q99497 | T154 | Sugiyama | PARK7 | MNGGHytysENRVEKDGLILtSRGPGTSFEFALAIVEALNG |
| Q99575 | S816 | Sugiyama | POP1 KIAA0061 | VAATGSHLCVLRSRKLLKQLsAWCGPSSEDSRGGRRAPGRG |
| Q99618 | S94 | Sugiyama | CDCA3 C8 GRCC8 TOME1 | ARtPMKTSsGDPPsPLVKQLsEVFETEDSKSNLPPEPVLPP |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | S54 | Sugiyama | TUBA1C TUBA6 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BQG0 | S11 | Sugiyama | MYBBP1A P160 | __________MEsRDPAQPMsPGEAtQsGARPADRYGLLKH |
| Q9BWH6 | T1384 | Sugiyama | RPAP1 KIAA1403 | FELYSQLPPLRQHYLQRLTStVLQNGVSET___________ |
| Q9BX95 | T114 | Sugiyama | SGPP1 SPP1 | AAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLFCF |
| Q9BY66 | S780 | Sugiyama | KDM5D HY HYA JARID1D KIAA0234 SMCY | FDTWANKVRVALEVEDGRKRsFEELRALESEARERRFPNSE |
| Q9BZD4 | S171 | Sugiyama | NUF2 CDCA1 NUF2R | KMQQLNAAHQEALMKLERLDsVPVEEQEEFKQLSDGIQELQ |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S221 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TyGtTTAPRDEDGstLFRGWsQEGPVKsPAECREEHsKtPE |
| Q9C0C2 | S429 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EEEAKGDAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAA |
| Q9C0C2 | S836 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GVLTAQDRVVGKPAQLGtQRsQEADVQDWEFRKRDsQGtys |
| Q9H2U2 | S317 | Sugiyama | PPA2 HSPC124 | DSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK___ |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H8Y8 | S451 | Sugiyama | GORASP2 GOLPH6 | DstPVsEKPVsAAVDANAsEsP___________________ |
| Q9HAP6 | S115 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | ELPKTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLK |
| Q9HCN8 | T70 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | RVRLHSHDIKYGSGSGQQSVtGVEAsDDANSyWRIRGGSEG |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQC3 | S107 | SIGNOR|PSP | RTN4 KIAA0886 NOGO My043 SP1507 | PPAPRGPLPAAPPVAPERQPsWDPsPVsstVPAPsPLsAAA |
| Q9NTJ3 | S22 | Sugiyama | SMC4 CAPC SMC4L1 | PRKGTQPSTARRREEGPPPPsPDGAssDAEPEPPsGRtEsP |
| Q9NUP9 | S115 | Sugiyama | LIN7C MALS3 VELI3 | ELPKTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLK |
| Q9NUU7 | S92 | Sugiyama | DDX19A DDX19L | NtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQGVYAMGFN |
| Q9NY61 | T366 | SIGNOR|EPSD|PSP | AATF CHE1 DED HSPC277 | EDYPSFMAKRFADFTVYRNRtLQKWHDKTKLASGKLGKGFG |
| Q9P032 | S45 | Sugiyama | NDUFAF4 C6orf66 HRPAP20 HSPC125 My013 | MKPSVAPRHPsTNSLLREQIsLyPEVKGEIARKDEKLLSFL |
| Q9P2N2 | S69 | Sugiyama | ARHGAP28 KIAA1314 | RINRMLsNESLHPPAFsRSNsEASVDSASMEDFWREIESIK |
| Q9UGV2 | S361 | Sugiyama | NDRG3 | sPFsRsVtsNQsDGtQESCEsPDVLDRHQTMEVsC______ |
| Q9UHB6 | S490 | Sugiyama | LIMA1 EPLIN SREBP3 PP624 | ENEEILERPAQLANAREtPHsPGVEDAPIAKVGVLAAsMEA |
| Q9UHI6 | S268 | Sugiyama | DDX20 DP103 GEMIN3 | EFLANALTKYMRDPTFVRLNsSDPSLIGLKQYYKVVNSYPL |
| Q9UKV8 | S387 | GPS6|SIGNOR|EPSD|PSP | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9ULD2 | S1203 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | QENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRL |
| Q9UMR2 | S93 | Sugiyama | DDX19B DBP5 DDX19 TDBP | NtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQGVYAMGFN |
| Q9UMZ2 | S752 | Sugiyama | SYNRG AP1GBP1 SYNG | VKGGQNSTAASTKyDVFRQLsLEGsGLGVEDLKDNtPSGKs |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UPN3 | S2769 | Sugiyama | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | EAIEKRLISPELANMIQIDSsEFSDHRAQIEKQEGIEVCAL |
| Q9UPN4 | S47 | EPSD|PSP | CEP131 AZI1 KIAA1118 | PPVSRRPGsAATtKPIVRsVsVVTGsEQKRKVLEATGPGGS |
| Q9UPN4 | S78 | EPSD|PSP | CEP131 AZI1 KIAA1118 | VLEATGPGGSQAINNLRRsNsttQVSQPRsGsPRPtEPtDF |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y385 | S184 | SIGNOR | UBE2J1 NCUBE1 CGI-76 HSPC153 HSPC205 | KSGSDSSQADQEAKELARQIsFKAEVNSSGKTISESDLNHS |
| Q9Y3X0 | S386 | Sugiyama | CCDC9 | DRWETKEGAAsPAPEtPQPtsPEtsPKETPMQPPEIPAPAH |
| Q9Y3X0 | T381 | Sugiyama | CCDC9 | YsDHDDRWETKEGAAsPAPEtPQPtsPEtsPKETPMQPPEI |
| Q9Y4H2 | S1203 | Sugiyama | IRS2 | RKssEGGVGVGPGGGDEPPtsPRQLQPAPPLAPQGRPWtPG |
| Q9Y580 | S136 | PSP|Sugiyama | RBM7 | RyERTMDNMTSSAQIIQRsFssPENFQRQAVMNsALRQMSY |
| Q9Y580 | S204 | PSP | RBM7 | SSSSQWRQGTPSSQRKVRMNsyPYLADRHYSREQRYTDHGs |
| Q9Y5A9 | S394 | Sugiyama | YTHDF2 HGRG8 | SQAGSGStPSEPHPVLEKLRsINNYNPKDFDWNLKHGRVFI |
| Q9Y6G9 | S516 | Sugiyama | DYNC1LI1 DNCLI1 | HAELDRITRKPVtVsPttPtsPtEGEAs_____________ |
| Q9Y6G9 | T513 | Sugiyama | DYNC1LI1 DNCLI1 | LDVHAELDRITRKPVtVsPttPtsPtEGEAs__________ |
| Q9Y6G9 | T515 | Sugiyama | DYNC1LI1 DNCLI1 | VHAELDRITRKPVtVsPttPtsPtEGEAs____________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 0.000007 | 5.148 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 0.000026 | 4.577 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 0.000042 | 4.373 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 0.000040 | 4.400 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 0.000054 | 4.269 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 0.000312 | 3.506 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 0.000325 | 3.488 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 0.000840 | 3.076 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 0.000871 | 3.060 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 0.000883 | 3.054 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 0.000936 | 3.029 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 0.001121 | 2.950 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 0.001121 | 2.950 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 0.001212 | 2.916 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 0.001193 | 2.923 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 0.001477 | 2.831 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 0.001444 | 2.840 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 0.001595 | 2.797 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 0.001605 | 2.795 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 0.001775 | 2.751 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 0.001982 | 2.703 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 0.002071 | 2.684 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 0.002273 | 2.643 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 0.002218 | 2.654 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 0.002302 | 2.638 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 0.002367 | 2.626 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 0.002476 | 2.606 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 0.002562 | 2.591 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 0.002533 | 2.596 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 0.002872 | 2.542 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 0.002929 | 2.533 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 0.003030 | 2.519 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 0.003588 | 2.445 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 0.003681 | 2.434 | 1 | 0 |
| Ca-dependent events | R-HSA-111996 | 0.004029 | 2.395 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 0.004171 | 2.380 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 0.004253 | 2.371 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 0.004689 | 2.329 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 0.005526 | 2.258 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 0.007682 | 2.115 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 0.007682 | 2.115 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 0.007656 | 2.116 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 0.006612 | 2.180 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 0.006879 | 2.162 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 0.006225 | 2.206 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 0.007438 | 2.129 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 0.007438 | 2.129 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 0.007438 | 2.129 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 0.007037 | 2.153 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 0.007626 | 2.118 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 0.006363 | 2.196 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 0.007438 | 2.129 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 0.006619 | 2.179 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 0.007051 | 2.152 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 0.007032 | 2.153 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 0.006426 | 2.192 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 0.005761 | 2.240 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 0.007619 | 2.118 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 0.006076 | 2.216 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 0.007722 | 2.112 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 0.007934 | 2.100 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 0.008323 | 2.080 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 0.008709 | 2.060 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 0.008808 | 2.055 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 0.008808 | 2.055 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 0.008596 | 2.066 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 0.008837 | 2.054 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 0.008902 | 2.051 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 0.009123 | 2.040 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 0.010012 | 1.999 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 0.010577 | 1.976 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 0.010577 | 1.976 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 0.010142 | 1.994 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 0.010329 | 1.986 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 0.010577 | 1.976 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 0.010786 | 1.967 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 0.010837 | 1.965 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 0.010837 | 1.965 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 0.012045 | 1.919 | 0 | 0 |
| PKA activation | R-HSA-163615 | 0.014224 | 1.847 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 0.014224 | 1.847 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 0.013704 | 1.863 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 0.014523 | 1.838 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 0.014820 | 1.829 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 0.014505 | 1.838 | 1 | 1 |
| Regulation of TP53 Activity | R-HSA-5633007 | 0.014559 | 1.837 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 0.013745 | 1.862 | 0 | 0 |
| M Phase | R-HSA-68886 | 0.015659 | 1.805 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 0.015789 | 1.802 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 0.016651 | 1.779 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 0.017317 | 1.762 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 0.017318 | 1.762 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 0.017952 | 1.746 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 0.018486 | 1.733 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 0.018628 | 1.730 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 0.018628 | 1.730 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 0.018924 | 1.723 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 0.019091 | 1.719 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 0.019091 | 1.719 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 0.020359 | 1.691 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 0.020359 | 1.691 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 0.021441 | 1.669 | 1 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 0.021455 | 1.668 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 0.021557 | 1.666 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 0.022088 | 1.656 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 0.022102 | 1.656 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 0.022582 | 1.646 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 0.023344 | 1.632 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 0.024611 | 1.609 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 0.023948 | 1.621 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 0.024658 | 1.608 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 0.024867 | 1.604 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 0.025562 | 1.592 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 0.025564 | 1.592 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 0.028665 | 1.543 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 0.028665 | 1.543 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 0.028665 | 1.543 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 0.028665 | 1.543 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 0.028665 | 1.543 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 0.029140 | 1.536 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 0.029438 | 1.531 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 0.029438 | 1.531 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 0.029566 | 1.529 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 0.029920 | 1.524 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 0.030268 | 1.519 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 0.030322 | 1.518 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 0.031898 | 1.496 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 0.032271 | 1.491 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 0.034655 | 1.460 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 0.033497 | 1.475 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 0.035263 | 1.453 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 0.036027 | 1.443 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 0.038442 | 1.415 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 0.038942 | 1.410 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 0.038942 | 1.410 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 0.039331 | 1.405 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 0.042083 | 1.376 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 0.040095 | 1.397 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 0.042157 | 1.375 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 0.040448 | 1.393 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 0.040448 | 1.393 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 0.040514 | 1.392 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 0.043009 | 1.366 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 0.043477 | 1.362 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 0.040095 | 1.397 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 0.043667 | 1.360 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 0.043882 | 1.358 | 1 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 0.045148 | 1.345 | 1 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 0.045369 | 1.343 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 0.045369 | 1.343 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 0.045442 | 1.343 | 1 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 0.046868 | 1.329 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 0.046893 | 1.329 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 0.048574 | 1.314 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 0.049843 | 1.302 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 0.058106 | 1.236 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 0.058106 | 1.236 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 0.052665 | 1.278 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 0.058106 | 1.236 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 0.052759 | 1.278 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 0.058106 | 1.236 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 0.058923 | 1.230 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 0.058923 | 1.230 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 0.063220 | 1.199 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 0.063220 | 1.199 | 1 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 0.071281 | 1.147 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 0.071281 | 1.147 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 0.071281 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 0.071281 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 0.071281 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 0.071281 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 0.071281 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 0.071281 | 1.147 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 0.071281 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 0.071281 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 0.071281 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 0.071281 | 1.147 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 0.066883 | 1.175 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 0.068255 | 1.166 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 0.067704 | 1.169 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 0.071184 | 1.148 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 0.070073 | 1.154 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 0.068313 | 1.165 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 0.066883 | 1.175 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 0.072447 | 1.140 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 0.072447 | 1.140 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 0.072447 | 1.140 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 0.072447 | 1.140 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 0.072447 | 1.140 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 0.072777 | 1.138 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 0.103149 | 0.987 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 0.195663 | 0.708 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 0.195663 | 0.708 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 0.195663 | 0.708 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 0.195663 | 0.708 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 0.195663 | 0.708 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 0.195663 | 0.708 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 0.195663 | 0.708 | 0 | 0 |
| TWIK-related spinal cord K+ channel (TRESK) | R-HSA-1299344 | 0.195663 | 0.708 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 0.195663 | 0.708 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 0.195663 | 0.708 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 0.195663 | 0.708 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 0.195663 | 0.708 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 0.103904 | 0.983 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 0.139679 | 0.855 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 0.139679 | 0.855 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 0.139679 | 0.855 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 0.139679 | 0.855 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 0.139679 | 0.855 | 0 | 0 |
| FGFR4 mutant receptor activation | R-HSA-1839128 | 0.278639 | 0.555 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 0.278639 | 0.555 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 0.278639 | 0.555 | 0 | 0 |
| t(4;14) translocations of FGFR3 | R-HSA-2033515 | 0.278639 | 0.555 | 0 | 0 |
| Signaling by FGFR3 fusions in cancer | R-HSA-8853334 | 0.278639 | 0.555 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 0.278639 | 0.555 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 0.278639 | 0.555 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 0.278639 | 0.555 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 0.278639 | 0.555 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 0.278639 | 0.555 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 0.278639 | 0.555 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 0.097246 | 1.012 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 0.097246 | 1.012 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 0.177611 | 0.751 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 0.177611 | 0.751 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 0.177611 | 0.751 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 0.177611 | 0.751 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 0.177611 | 0.751 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 0.083326 | 1.079 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 0.099443 | 1.002 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 0.099443 | 1.002 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 0.099443 | 1.002 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 0.099443 | 1.002 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 0.099443 | 1.002 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 0.144290 | 0.841 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 0.216875 | 0.664 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 0.216875 | 0.664 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 0.353059 | 0.452 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 0.353059 | 0.452 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 0.353059 | 0.452 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 0.353059 | 0.452 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 0.353059 | 0.452 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 0.353059 | 0.452 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 0.116881 | 0.932 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 0.170130 | 0.769 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 0.170130 | 0.769 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 0.135542 | 0.868 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 0.135542 | 0.868 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 0.256792 | 0.590 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 0.256792 | 0.590 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 0.256792 | 0.590 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 0.109190 | 0.962 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 0.109190 | 0.962 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 0.197165 | 0.705 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 0.197165 | 0.705 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 0.197165 | 0.705 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 0.197165 | 0.705 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 0.197165 | 0.705 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 0.197165 | 0.705 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 0.155318 | 0.809 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 0.124229 | 0.906 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 0.124229 | 0.906 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 0.124229 | 0.906 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 0.081709 | 1.088 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 0.081709 | 1.088 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 0.074837 | 1.126 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 0.112861 | 0.947 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 0.176090 | 0.754 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 0.176090 | 0.754 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 0.225140 | 0.648 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 0.296811 | 0.528 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 0.296811 | 0.528 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 0.296811 | 0.528 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 0.296811 | 0.528 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 0.296811 | 0.528 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 0.419806 | 0.377 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 0.419806 | 0.377 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 0.419806 | 0.377 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 0.419806 | 0.377 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 0.419806 | 0.377 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 0.419806 | 0.377 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 0.197738 | 0.704 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 0.197738 | 0.704 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 0.197738 | 0.704 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 0.113360 | 0.946 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 0.253812 | 0.595 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 0.253812 | 0.595 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 0.112081 | 0.950 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 0.154643 | 0.811 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 0.154643 | 0.811 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 0.220137 | 0.657 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 0.336486 | 0.473 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 0.336486 | 0.473 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 0.336486 | 0.473 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 0.336486 | 0.473 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 0.336486 | 0.473 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 0.100547 | 0.998 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 0.282955 | 0.548 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 0.282955 | 0.548 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 0.282955 | 0.548 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 0.282955 | 0.548 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 0.133872 | 0.873 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 0.243165 | 0.614 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 0.077385 | 1.111 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 0.145519 | 0.837 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 0.145519 | 0.837 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 0.145519 | 0.837 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 0.145519 | 0.837 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 0.157644 | 0.802 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 0.178064 | 0.749 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 0.202159 | 0.694 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 0.202159 | 0.694 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 0.266697 | 0.574 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 0.312360 | 0.505 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 0.312360 | 0.505 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 0.375462 | 0.425 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 0.375462 | 0.425 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 0.375462 | 0.425 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 0.375462 | 0.425 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 0.479670 | 0.319 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 0.479670 | 0.319 | 0 | 0 |
| betaKlotho-mediated ligand binding | R-HSA-1307965 | 0.479670 | 0.319 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 0.479670 | 0.319 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 0.479670 | 0.319 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 0.479670 | 0.319 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 0.479670 | 0.319 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 0.479670 | 0.319 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 0.479670 | 0.319 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 0.479670 | 0.319 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 0.479670 | 0.319 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 0.170228 | 0.769 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 0.192583 | 0.715 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 0.115492 | 0.937 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 0.219066 | 0.659 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 0.219066 | 0.659 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 0.251018 | 0.600 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 0.110825 | 0.955 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 0.290615 | 0.537 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 0.290615 | 0.537 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 0.290615 | 0.537 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 0.290615 | 0.537 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 0.290615 | 0.537 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 0.138287 | 0.859 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 0.341834 | 0.466 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 0.341834 | 0.466 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 0.341834 | 0.466 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 0.126262 | 0.899 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 0.157709 | 0.802 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 0.157709 | 0.802 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 0.150071 | 0.824 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 0.254186 | 0.595 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 0.314803 | 0.502 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 0.413462 | 0.384 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 0.272296 | 0.565 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 0.371205 | 0.430 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 0.371205 | 0.430 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 0.179168 | 0.747 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 0.339152 | 0.470 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 0.212177 | 0.673 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 0.312970 | 0.504 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 0.312970 | 0.504 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 0.224538 | 0.649 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 0.334091 | 0.476 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 0.334091 | 0.476 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 0.334091 | 0.476 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 0.334091 | 0.476 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 0.363559 | 0.439 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 0.400320 | 0.398 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 0.400320 | 0.398 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 0.400320 | 0.398 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 0.450272 | 0.347 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 0.450272 | 0.347 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 0.450272 | 0.347 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 0.533360 | 0.273 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 0.533360 | 0.273 | 0 | 0 |
| IRS activation | R-HSA-74713 | 0.533360 | 0.273 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 0.533360 | 0.273 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 0.235264 | 0.628 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 0.233009 | 0.633 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 0.328196 | 0.484 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 0.355329 | 0.449 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 0.300081 | 0.523 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 0.387925 | 0.411 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 0.429044 | 0.367 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 0.309730 | 0.509 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 0.309730 | 0.509 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 0.331755 | 0.479 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 0.412161 | 0.385 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 0.412161 | 0.385 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 0.485733 | 0.314 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 0.485733 | 0.314 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 0.255334 | 0.593 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 0.356696 | 0.448 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 0.457258 | 0.340 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 0.331613 | 0.479 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 0.374162 | 0.427 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 0.286244 | 0.543 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 0.404502 | 0.393 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 0.484864 | 0.314 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 0.519732 | 0.284 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 0.519732 | 0.284 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 0.519732 | 0.284 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 0.519732 | 0.284 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 0.581513 | 0.235 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 0.581513 | 0.235 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 0.581513 | 0.235 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 0.581513 | 0.235 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 0.581513 | 0.235 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 0.581513 | 0.235 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 0.581513 | 0.235 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 0.581513 | 0.235 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 0.581513 | 0.235 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 0.581513 | 0.235 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 0.442562 | 0.354 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 0.442562 | 0.354 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 0.442562 | 0.354 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 0.461035 | 0.336 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 0.461035 | 0.336 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 0.461035 | 0.336 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 0.483305 | 0.316 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 0.511774 | 0.291 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 0.480113 | 0.319 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 0.506272 | 0.296 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 0.506272 | 0.296 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 0.502051 | 0.299 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 0.498605 | 0.302 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 0.537921 | 0.269 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 0.537921 | 0.269 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 0.495672 | 0.305 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 0.486824 | 0.313 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 0.516863 | 0.287 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 0.550756 | 0.259 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 0.563246 | 0.249 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 0.563246 | 0.249 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 0.583072 | 0.234 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 0.583072 | 0.234 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 0.583072 | 0.234 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 0.583072 | 0.234 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 0.552565 | 0.258 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 0.544284 | 0.264 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 0.587707 | 0.231 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 0.587707 | 0.231 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 0.587707 | 0.231 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 0.584925 | 0.233 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 0.591154 | 0.228 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 0.591154 | 0.228 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 0.535899 | 0.271 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 0.170421 | 0.768 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 0.091788 | 1.037 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 0.418877 | 0.378 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 0.122721 | 0.911 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 0.266697 | 0.574 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 0.552565 | 0.258 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 0.266369 | 0.575 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 0.552193 | 0.258 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 0.541794 | 0.266 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 0.481682 | 0.317 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 0.572188 | 0.242 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 0.307020 | 0.513 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 0.517982 | 0.286 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 0.176090 | 0.754 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 0.197030 | 0.705 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 0.197030 | 0.705 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 0.152932 | 0.816 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 0.080564 | 1.094 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 0.400320 | 0.398 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 0.528771 | 0.277 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 0.502051 | 0.299 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 0.197030 | 0.705 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 0.176090 | 0.754 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 0.169182 | 0.772 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 0.436186 | 0.360 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 0.209352 | 0.679 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 0.397941 | 0.400 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 0.119094 | 0.924 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 0.355329 | 0.449 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 0.519732 | 0.284 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 0.480113 | 0.319 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 0.074837 | 1.126 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 0.282955 | 0.548 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 0.269155 | 0.570 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 0.144290 | 0.841 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 0.101964 | 0.992 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 0.137552 | 0.862 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 0.502051 | 0.299 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 0.461035 | 0.336 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 0.157644 | 0.802 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 0.363559 | 0.439 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 0.400320 | 0.398 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 0.459774 | 0.337 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 0.563600 | 0.249 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 0.356696 | 0.448 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 0.297935 | 0.526 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 0.528771 | 0.277 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 0.241261 | 0.618 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 0.097246 | 1.012 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 0.170130 | 0.769 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 0.225140 | 0.648 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 0.375462 | 0.425 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 0.254186 | 0.595 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 0.254849 | 0.594 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 0.581513 | 0.235 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 0.587707 | 0.231 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 0.303754 | 0.517 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 0.243165 | 0.614 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 0.169182 | 0.772 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 0.459923 | 0.337 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 0.550756 | 0.259 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 0.178064 | 0.749 | 1 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 0.326987 | 0.485 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 0.426664 | 0.370 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 0.314166 | 0.503 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 0.168725 | 0.773 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 0.563246 | 0.249 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 0.292665 | 0.534 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 0.549369 | 0.260 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 0.139679 | 0.855 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 0.083326 | 1.079 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 0.075671 | 1.121 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 0.336486 | 0.473 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 0.375462 | 0.425 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 0.479670 | 0.319 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 0.112229 | 0.950 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 0.102782 | 0.988 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 0.533360 | 0.273 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 0.484864 | 0.314 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 0.581513 | 0.235 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 0.552193 | 0.258 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 0.113352 | 0.946 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 0.523326 | 0.281 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 0.459923 | 0.337 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 0.461420 | 0.336 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 0.503259 | 0.298 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 0.137552 | 0.862 | 0 | 0 |
| S Phase | R-HSA-69242 | 0.204712 | 0.689 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 0.369625 | 0.432 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 0.271361 | 0.566 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 0.138134 | 0.860 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 0.138134 | 0.860 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 0.140025 | 0.854 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 0.314803 | 0.502 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 0.413462 | 0.384 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 0.359930 | 0.444 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 0.440153 | 0.356 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 0.519732 | 0.284 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 0.519732 | 0.284 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 0.481682 | 0.317 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 0.460315 | 0.337 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 0.561099 | 0.251 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 0.137552 | 0.862 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 0.194797 | 0.710 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 0.253812 | 0.595 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 0.222949 | 0.652 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 0.119122 | 0.924 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 0.431657 | 0.365 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 0.537921 | 0.269 | 1 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 0.541794 | 0.266 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 0.251018 | 0.600 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 0.125823 | 0.900 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 0.384807 | 0.415 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 0.567966 | 0.246 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 0.296811 | 0.528 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 0.197738 | 0.704 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 0.150519 | 0.822 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 0.157644 | 0.802 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 0.196685 | 0.706 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 0.224538 | 0.649 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 0.533360 | 0.273 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 0.533360 | 0.273 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 0.533360 | 0.273 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 0.280625 | 0.552 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 0.429044 | 0.367 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 0.130517 | 0.884 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 0.485733 | 0.314 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 0.419087 | 0.378 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 0.483305 | 0.316 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 0.511774 | 0.291 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 0.488735 | 0.311 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 0.579985 | 0.237 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 0.292665 | 0.534 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 0.339306 | 0.469 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 0.339306 | 0.469 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 0.175033 | 0.757 | 1 | 1 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 0.272296 | 0.565 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 0.347181 | 0.459 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 0.563600 | 0.249 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 0.284509 | 0.546 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 0.284509 | 0.546 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 0.355329 | 0.449 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 0.356696 | 0.448 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 0.116881 | 0.932 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 0.328196 | 0.484 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 0.519732 | 0.284 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 0.498605 | 0.302 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 0.183249 | 0.737 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 0.455004 | 0.342 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 0.214181 | 0.669 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 0.219321 | 0.659 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 0.147832 | 0.830 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 0.197030 | 0.705 | 1 | 0 |
| Nef and signal transduction | R-HSA-164944 | 0.076564 | 1.116 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 0.139679 | 0.855 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 0.097246 | 1.012 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 0.109190 | 0.962 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 0.207556 | 0.683 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 0.413462 | 0.384 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 0.363559 | 0.439 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 0.092938 | 1.032 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 0.581513 | 0.235 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 0.552193 | 0.258 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 0.502051 | 0.299 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 0.587010 | 0.231 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 0.296680 | 0.528 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 0.364078 | 0.439 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 0.263178 | 0.580 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 0.363559 | 0.439 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 0.412161 | 0.385 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 0.194788 | 0.710 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 0.481682 | 0.317 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 0.081757 | 1.087 | 1 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 0.455381 | 0.342 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 0.119907 | 0.921 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 0.137552 | 0.862 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 0.169901 | 0.770 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 0.290615 | 0.537 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 0.196685 | 0.706 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 0.334091 | 0.476 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 0.485733 | 0.314 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 0.484864 | 0.314 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 0.407104 | 0.390 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 0.254849 | 0.594 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 0.423576 | 0.373 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 0.296811 | 0.528 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 0.371205 | 0.430 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 0.256157 | 0.591 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 0.231085 | 0.636 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 0.194797 | 0.710 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 0.514653 | 0.288 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 0.131948 | 0.880 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 0.103571 | 0.985 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 0.480113 | 0.319 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 0.157709 | 0.802 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 0.341874 | 0.466 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 0.276515 | 0.558 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 0.318545 | 0.497 | 1 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 0.154643 | 0.811 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 0.098518 | 1.006 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 0.107796 | 0.967 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 0.256717 | 0.591 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 0.201836 | 0.695 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 0.228658 | 0.641 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 0.139679 | 0.855 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 0.119907 | 0.921 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 0.144290 | 0.841 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 0.216875 | 0.664 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 0.353059 | 0.452 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 0.353059 | 0.452 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 0.353059 | 0.452 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 0.170130 | 0.769 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 0.225140 | 0.648 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 0.225140 | 0.648 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 0.419806 | 0.377 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 0.419806 | 0.377 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 0.253812 | 0.595 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 0.336486 | 0.473 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 0.336486 | 0.473 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 0.336486 | 0.473 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 0.243165 | 0.614 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 0.115700 | 0.937 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 0.312360 | 0.505 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 0.312360 | 0.505 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 0.479670 | 0.319 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 0.186471 | 0.729 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 0.238726 | 0.622 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 0.224696 | 0.648 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 0.224696 | 0.648 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 0.371205 | 0.430 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 0.312970 | 0.504 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 0.290702 | 0.537 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 0.169676 | 0.770 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 0.363559 | 0.439 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 0.347181 | 0.459 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 0.429044 | 0.367 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 0.485733 | 0.314 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 0.347797 | 0.459 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 0.457258 | 0.340 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 0.317134 | 0.499 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 0.581513 | 0.235 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 0.581513 | 0.235 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 0.581513 | 0.235 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 0.552193 | 0.258 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 0.458580 | 0.339 | 1 | 1 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 0.523422 | 0.281 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 0.283768 | 0.547 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 0.113296 | 0.946 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 0.125158 | 0.903 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 0.328196 | 0.484 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 0.147832 | 0.830 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 0.354502 | 0.450 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 0.254849 | 0.594 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 0.374056 | 0.427 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 0.495457 | 0.305 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 0.157644 | 0.802 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 0.236385 | 0.626 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 0.244480 | 0.612 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 0.150899 | 0.821 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 0.423069 | 0.374 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 0.341834 | 0.466 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 0.137552 | 0.862 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 0.279409 | 0.554 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 0.528771 | 0.277 | 1 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 0.275613 | 0.560 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 0.275613 | 0.560 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 0.256792 | 0.590 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 0.197738 | 0.704 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 0.174490 | 0.758 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 0.211724 | 0.674 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 0.484864 | 0.314 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 0.356362 | 0.448 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 0.528771 | 0.277 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 0.528771 | 0.277 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 0.183287 | 0.737 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 0.478625 | 0.320 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 0.088671 | 1.052 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 0.174490 | 0.758 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 0.211636 | 0.674 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 0.103546 | 0.985 | 1 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 0.209352 | 0.679 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 0.457258 | 0.340 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 0.552193 | 0.258 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 0.165782 | 0.780 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 0.396381 | 0.402 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 0.550756 | 0.259 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 0.445958 | 0.351 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 0.519513 | 0.284 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 0.562299 | 0.250 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 0.083326 | 1.079 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 0.216875 | 0.664 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 0.155318 | 0.809 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 0.479670 | 0.319 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 0.103546 | 0.985 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 0.272296 | 0.565 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 0.533360 | 0.273 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 0.374162 | 0.427 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 0.160799 | 0.794 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 0.409181 | 0.388 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 0.581513 | 0.235 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 0.461175 | 0.336 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 0.583072 | 0.234 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 0.177469 | 0.751 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 0.332989 | 0.478 | 1 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 0.484864 | 0.314 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 0.440687 | 0.356 | 1 | 0 |
| Reproduction | R-HSA-1474165 | 0.083820 | 1.077 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 0.105967 | 0.975 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 0.312360 | 0.505 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 0.266369 | 0.575 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 0.436186 | 0.360 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 0.205797 | 0.687 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 0.292036 | 0.535 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 0.109190 | 0.962 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 0.197738 | 0.704 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 0.280071 | 0.553 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 0.184213 | 0.735 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 0.459923 | 0.337 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 0.572188 | 0.242 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 0.339306 | 0.469 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 0.150071 | 0.824 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 0.192746 | 0.715 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 0.459923 | 0.337 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 0.162506 | 0.789 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 0.387925 | 0.411 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 0.452708 | 0.344 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 0.363559 | 0.439 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 0.297935 | 0.526 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 0.353059 | 0.452 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 0.116881 | 0.932 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 0.243165 | 0.614 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 0.375462 | 0.425 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 0.375462 | 0.425 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 0.479670 | 0.319 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 0.341834 | 0.466 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 0.254186 | 0.595 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 0.413462 | 0.384 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 0.371205 | 0.430 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 0.334091 | 0.476 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 0.450272 | 0.347 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 0.450272 | 0.347 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 0.533360 | 0.273 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 0.533360 | 0.273 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 0.356696 | 0.448 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 0.581513 | 0.235 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 0.583072 | 0.234 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 0.368157 | 0.434 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 0.157709 | 0.802 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 0.157709 | 0.802 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 0.480113 | 0.319 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 0.286795 | 0.542 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 0.376616 | 0.424 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 0.436186 | 0.360 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 0.457304 | 0.340 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 0.433633 | 0.363 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 0.268025 | 0.572 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 0.144290 | 0.841 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 0.116881 | 0.932 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 0.312360 | 0.505 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 0.552193 | 0.258 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 0.150519 | 0.822 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 0.086025 | 1.065 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 0.109190 | 0.962 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 0.579985 | 0.237 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 0.256792 | 0.590 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 0.419806 | 0.377 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 0.129082 | 0.889 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 0.290702 | 0.537 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 0.450272 | 0.347 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 0.583072 | 0.234 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 0.484041 | 0.315 | 1 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 0.376404 | 0.424 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 0.101842 | 0.992 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 0.089874 | 1.046 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 0.253812 | 0.595 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 0.356696 | 0.448 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 0.334512 | 0.476 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 0.144290 | 0.841 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 0.216875 | 0.664 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 0.296811 | 0.528 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 0.336486 | 0.473 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 0.334091 | 0.476 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 0.450272 | 0.347 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 0.533360 | 0.273 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 0.533360 | 0.273 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 0.404502 | 0.393 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 0.423576 | 0.373 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 0.461420 | 0.336 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 0.552193 | 0.258 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 0.552193 | 0.258 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 0.433951 | 0.363 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 0.474563 | 0.324 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 0.563246 | 0.249 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 0.156941 | 0.804 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 0.253812 | 0.595 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 0.140025 | 0.854 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 0.563462 | 0.249 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 0.207556 | 0.683 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 0.160452 | 0.795 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 0.137120 | 0.863 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 0.413462 | 0.384 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 0.363559 | 0.439 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 0.160452 | 0.795 | 0 | 0 |
| Depurination | R-HSA-73927 | 0.222949 | 0.652 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 0.353059 | 0.452 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 0.125158 | 0.903 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 0.282955 | 0.548 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 0.413462 | 0.384 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 0.369625 | 0.432 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 0.137552 | 0.862 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 0.570144 | 0.244 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 0.385381 | 0.414 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 0.450272 | 0.347 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 0.363935 | 0.439 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 0.583072 | 0.234 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 0.183249 | 0.737 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 0.183249 | 0.737 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 0.083336 | 1.079 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 0.541794 | 0.266 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 0.533360 | 0.273 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 0.331755 | 0.479 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 0.319841 | 0.495 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 0.519732 | 0.284 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 0.550756 | 0.259 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 0.591687 | 0.228 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 0.593032 | 0.227 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 0.593032 | 0.227 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 0.593461 | 0.227 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 0.593461 | 0.227 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 0.598427 | 0.223 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 0.603273 | 0.219 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 0.608814 | 0.216 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 0.608814 | 0.216 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 0.608814 | 0.216 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 0.608814 | 0.216 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 0.608814 | 0.216 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 0.610292 | 0.214 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 0.611269 | 0.214 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 0.612349 | 0.213 | 1 | 1 |
| Protein lipoylation | R-HSA-9857492 | 0.612349 | 0.213 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 0.612349 | 0.213 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 0.612349 | 0.213 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 0.612349 | 0.213 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 0.612349 | 0.213 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 0.612349 | 0.213 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 0.612349 | 0.213 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 0.612349 | 0.213 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 0.612349 | 0.213 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 0.613262 | 0.212 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 0.613262 | 0.212 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 0.613262 | 0.212 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 0.613262 | 0.212 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 0.615451 | 0.211 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 0.617839 | 0.209 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 0.618472 | 0.209 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 0.623853 | 0.205 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 0.623853 | 0.205 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 0.624700 | 0.204 | 0 | 0 |
| Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) | R-HSA-3656244 | 0.624700 | 0.204 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 0.624700 | 0.204 | 0 | 0 |
| Defective ST3GAL3 causes MCT12 and EIEE15 | R-HSA-3656243 | 0.624700 | 0.204 | 0 | 0 |
| Defective CHST6 causes MCDC1 | R-HSA-3656225 | 0.624700 | 0.204 | 0 | 0 |
| Defective CYP11A1 causes AICSR | R-HSA-5579026 | 0.624700 | 0.204 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 0.624700 | 0.204 | 1 | 1 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 0.624700 | 0.204 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 0.624700 | 0.204 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 0.624700 | 0.204 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 0.624700 | 0.204 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 0.624700 | 0.204 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 0.627739 | 0.202 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 0.627739 | 0.202 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 0.627739 | 0.202 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 0.629310 | 0.201 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 0.632856 | 0.199 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 0.633910 | 0.198 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 0.633910 | 0.198 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 0.635964 | 0.197 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 0.635964 | 0.197 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 0.638566 | 0.195 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 0.639800 | 0.194 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 0.640026 | 0.194 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 0.640026 | 0.194 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 0.640026 | 0.194 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 0.640026 | 0.194 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 0.640026 | 0.194 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 0.640026 | 0.194 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 0.640026 | 0.194 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 0.640026 | 0.194 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 0.641462 | 0.193 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 0.651495 | 0.186 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 0.651495 | 0.186 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 0.651798 | 0.186 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 0.651798 | 0.186 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 0.651798 | 0.186 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 0.654014 | 0.184 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 0.654638 | 0.184 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 0.654895 | 0.184 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 0.654895 | 0.184 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 0.655615 | 0.183 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 0.655615 | 0.183 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 0.655615 | 0.183 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 0.655615 | 0.183 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 0.655615 | 0.183 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 0.655615 | 0.183 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 0.655615 | 0.183 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 0.657179 | 0.182 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 0.657179 | 0.182 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 0.659632 | 0.181 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 0.660316 | 0.180 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 0.663432 | 0.178 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 0.663432 | 0.178 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 0.663432 | 0.178 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 0.663432 | 0.178 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 0.663432 | 0.178 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 0.663432 | 0.178 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 0.663432 | 0.178 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 0.663432 | 0.178 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 0.663432 | 0.178 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 0.663432 | 0.178 | 0 | 0 |
| Electron transport from NADPH to Ferredoxin | R-HSA-2395516 | 0.663432 | 0.178 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 0.663432 | 0.178 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 0.663432 | 0.178 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 0.663432 | 0.178 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 0.663432 | 0.178 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 0.663432 | 0.178 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 0.663432 | 0.178 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 0.663432 | 0.178 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 0.666122 | 0.176 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 0.666122 | 0.176 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 0.666122 | 0.176 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 0.666122 | 0.176 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 0.666614 | 0.176 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 0.667384 | 0.176 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 0.671369 | 0.173 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 0.671369 | 0.173 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 0.673400 | 0.172 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 0.675575 | 0.170 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 0.675575 | 0.170 | 1 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 0.676379 | 0.170 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 0.676379 | 0.170 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 0.676379 | 0.170 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 0.676379 | 0.170 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 0.681312 | 0.167 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 0.681312 | 0.167 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 0.683352 | 0.165 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 0.683352 | 0.165 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 0.687385 | 0.163 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 0.687680 | 0.163 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 0.687680 | 0.163 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 0.690668 | 0.161 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 0.690668 | 0.161 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 0.690668 | 0.161 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 0.690668 | 0.161 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 0.690668 | 0.161 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 0.690668 | 0.161 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 0.691898 | 0.160 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 0.693497 | 0.159 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 0.695581 | 0.158 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 0.695581 | 0.158 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 0.695581 | 0.158 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 0.696118 | 0.157 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 0.696202 | 0.157 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 0.696202 | 0.157 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 0.696202 | 0.157 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 0.696202 | 0.157 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 0.696355 | 0.157 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 0.698169 | 0.156 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 0.698169 | 0.156 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 0.698169 | 0.156 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 0.698169 | 0.156 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 0.698169 | 0.156 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 0.698169 | 0.156 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 0.698169 | 0.156 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 0.698169 | 0.156 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 0.698169 | 0.156 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 0.698169 | 0.156 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 0.698169 | 0.156 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 0.698169 | 0.156 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 0.698169 | 0.156 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 0.698169 | 0.156 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 0.698169 | 0.156 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 0.698169 | 0.156 | 0 | 0 |
| RSK activation | R-HSA-444257 | 0.698169 | 0.156 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 0.698169 | 0.156 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 0.698795 | 0.156 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 0.698795 | 0.156 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 0.701770 | 0.154 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 0.704610 | 0.152 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 0.704610 | 0.152 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 0.704610 | 0.152 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 0.706417 | 0.151 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 0.709419 | 0.149 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 0.711573 | 0.148 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 0.713705 | 0.146 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 0.713705 | 0.146 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 0.713705 | 0.146 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 0.713705 | 0.146 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 0.713705 | 0.146 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 0.713705 | 0.146 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 0.713710 | 0.146 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 0.715091 | 0.146 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 0.715869 | 0.145 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 0.719854 | 0.143 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 0.725943 | 0.139 | 1 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 0.726363 | 0.139 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 0.727326 | 0.138 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 0.728094 | 0.138 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 0.729323 | 0.137 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 0.729323 | 0.137 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 0.729323 | 0.137 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 0.729323 | 0.137 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 0.729323 | 0.137 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 0.729323 | 0.137 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 0.729323 | 0.137 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 0.729323 | 0.137 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 0.729323 | 0.137 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 0.729323 | 0.137 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 0.729323 | 0.137 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 0.729323 | 0.137 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 0.733057 | 0.135 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 0.735285 | 0.134 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 0.735285 | 0.134 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 0.735784 | 0.133 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 0.735784 | 0.133 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 0.736446 | 0.133 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 0.739589 | 0.131 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 0.739953 | 0.131 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 0.740247 | 0.131 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 0.740720 | 0.130 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 0.741949 | 0.130 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 0.743531 | 0.129 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 0.744856 | 0.128 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 0.745345 | 0.128 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 0.748311 | 0.126 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 0.750117 | 0.125 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 0.750117 | 0.125 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 0.750117 | 0.125 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 0.750117 | 0.125 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 0.751155 | 0.124 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 0.751362 | 0.124 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 0.751362 | 0.124 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 0.751362 | 0.124 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 0.751362 | 0.124 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 0.752596 | 0.123 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 0.752775 | 0.123 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 0.755277 | 0.122 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 0.755462 | 0.122 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 0.755462 | 0.122 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 0.755462 | 0.122 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 0.757262 | 0.121 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 0.757262 | 0.121 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 0.757262 | 0.121 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 0.757262 | 0.121 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 0.757262 | 0.121 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 0.757262 | 0.121 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 0.757262 | 0.121 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 0.757262 | 0.121 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 0.757262 | 0.121 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 0.757262 | 0.121 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 0.757262 | 0.121 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 0.757262 | 0.121 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 0.757262 | 0.121 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 0.757262 | 0.121 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 0.757262 | 0.121 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 0.757262 | 0.121 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 0.758573 | 0.120 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 0.760402 | 0.119 | 1 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 0.765620 | 0.116 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 0.766082 | 0.116 | 1 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 0.766291 | 0.116 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 0.766291 | 0.116 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 0.766291 | 0.116 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 0.766291 | 0.116 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 0.766915 | 0.115 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 0.768411 | 0.114 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 0.772060 | 0.112 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 0.772060 | 0.112 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 0.774295 | 0.111 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 0.774295 | 0.111 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 0.774295 | 0.111 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 0.774295 | 0.111 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 0.774295 | 0.111 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 0.774295 | 0.111 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 0.774295 | 0.111 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 0.779232 | 0.108 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 0.779232 | 0.108 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 0.779232 | 0.108 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 0.780373 | 0.108 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 0.781601 | 0.107 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 0.782319 | 0.107 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 0.782319 | 0.107 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 0.782319 | 0.107 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 0.782319 | 0.107 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 0.782319 | 0.107 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 0.782319 | 0.107 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 0.782319 | 0.107 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 0.782319 | 0.107 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 0.782319 | 0.107 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 0.782319 | 0.107 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 0.782319 | 0.107 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 0.782319 | 0.107 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 0.783288 | 0.106 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 0.787154 | 0.104 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 0.789917 | 0.102 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 0.791848 | 0.101 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 0.791848 | 0.101 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 0.791848 | 0.101 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 0.791848 | 0.101 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 0.791848 | 0.101 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 0.795413 | 0.099 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 0.796074 | 0.099 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 0.796074 | 0.099 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 0.796074 | 0.099 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 0.797141 | 0.098 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 0.804791 | 0.094 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 0.804791 | 0.094 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 0.804791 | 0.094 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 0.804791 | 0.094 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 0.804791 | 0.094 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 0.804791 | 0.094 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 0.804791 | 0.094 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 0.804837 | 0.094 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 0.804890 | 0.094 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 0.804890 | 0.094 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 0.808183 | 0.092 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 0.808183 | 0.092 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 0.808183 | 0.092 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 0.808267 | 0.092 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 0.809735 | 0.092 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 0.809810 | 0.092 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 0.813302 | 0.090 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 0.814226 | 0.089 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 0.815371 | 0.089 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 0.817530 | 0.087 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 0.820982 | 0.086 | 1 | 0 |
| Potassium Channels | R-HSA-1296071 | 0.821437 | 0.085 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 0.823366 | 0.084 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 0.823366 | 0.084 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 0.823366 | 0.084 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 0.823366 | 0.084 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 0.824537 | 0.084 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 0.824945 | 0.084 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 0.824945 | 0.084 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 0.824945 | 0.084 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 0.824945 | 0.084 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 0.824945 | 0.084 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 0.824945 | 0.084 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 0.824945 | 0.084 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 0.824945 | 0.084 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 0.824945 | 0.084 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 0.824945 | 0.084 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 0.824945 | 0.084 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 0.824945 | 0.084 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 0.824945 | 0.084 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 0.824945 | 0.084 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 0.824945 | 0.084 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 0.824945 | 0.084 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 0.824945 | 0.084 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 0.824945 | 0.084 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 0.824945 | 0.084 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 0.824966 | 0.084 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 0.825371 | 0.083 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 0.827485 | 0.082 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 0.832146 | 0.080 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 0.834743 | 0.078 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 0.834743 | 0.078 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 0.834743 | 0.078 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 0.836888 | 0.077 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 0.837459 | 0.077 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 0.837459 | 0.077 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 0.837459 | 0.077 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 0.838081 | 0.077 | 1 | 1 |
| Signaling by TGFBR3 | R-HSA-9839373 | 0.838081 | 0.077 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 0.839319 | 0.076 | 1 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 0.841789 | 0.075 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 0.843018 | 0.074 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 0.843018 | 0.074 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 0.843018 | 0.074 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 0.843018 | 0.074 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 0.843018 | 0.074 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 0.843018 | 0.074 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 0.843018 | 0.074 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 0.843018 | 0.074 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 0.843018 | 0.074 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 0.843766 | 0.074 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 0.846150 | 0.073 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 0.846252 | 0.073 | 1 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 0.850380 | 0.070 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 0.850380 | 0.070 | 1 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 0.850527 | 0.070 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 0.850527 | 0.070 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 0.850527 | 0.070 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 0.850527 | 0.070 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 0.856866 | 0.067 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 0.856866 | 0.067 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 0.858083 | 0.066 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 0.858286 | 0.066 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 0.859227 | 0.066 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 0.859227 | 0.066 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 0.859227 | 0.066 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 0.859227 | 0.066 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 0.859227 | 0.066 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 0.859227 | 0.066 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 0.859227 | 0.066 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 0.859227 | 0.066 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 0.859227 | 0.066 | 0 | 0 |
| Kinesins | R-HSA-983189 | 0.861221 | 0.065 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 0.862294 | 0.064 | 1 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 0.862630 | 0.064 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 0.862630 | 0.064 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 0.862630 | 0.064 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 0.862630 | 0.064 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 0.864570 | 0.063 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 0.865314 | 0.063 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 0.866922 | 0.062 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 0.866922 | 0.062 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 0.869318 | 0.061 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 0.870948 | 0.060 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 0.871662 | 0.060 | 1 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 0.872826 | 0.059 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 0.873763 | 0.059 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 0.873763 | 0.059 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 0.873763 | 0.059 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 0.873763 | 0.059 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 0.873763 | 0.059 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 0.873763 | 0.059 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 0.873763 | 0.059 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 0.873763 | 0.059 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 0.873763 | 0.059 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 0.873763 | 0.059 | 1 | 1 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 0.873763 | 0.059 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 0.873763 | 0.059 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 0.873763 | 0.059 | 1 | 1 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 0.873763 | 0.059 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 0.873763 | 0.059 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 0.873763 | 0.059 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 0.873763 | 0.059 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 0.873828 | 0.059 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 0.873828 | 0.059 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 0.873828 | 0.059 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 0.874274 | 0.058 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 0.875120 | 0.058 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 0.875975 | 0.058 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 0.876350 | 0.057 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 0.876350 | 0.057 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 0.876350 | 0.057 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 0.877017 | 0.057 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 0.877191 | 0.057 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 0.879571 | 0.056 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 0.880411 | 0.055 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 0.882679 | 0.054 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 0.882851 | 0.054 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 0.883179 | 0.054 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 0.884179 | 0.053 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 0.884179 | 0.053 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 0.885181 | 0.053 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 0.885181 | 0.053 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 0.886799 | 0.052 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 0.886799 | 0.052 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 0.886799 | 0.052 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 0.886799 | 0.052 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 0.886799 | 0.052 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 0.886799 | 0.052 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 0.886799 | 0.052 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 0.886799 | 0.052 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 0.886799 | 0.052 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 0.886799 | 0.052 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 0.886799 | 0.052 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 0.887072 | 0.052 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 0.888406 | 0.051 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 0.890759 | 0.050 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 0.890759 | 0.050 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 0.891245 | 0.050 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 0.893443 | 0.049 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 0.893443 | 0.049 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 0.893443 | 0.049 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 0.893738 | 0.049 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 0.893738 | 0.049 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 0.893835 | 0.049 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 0.894433 | 0.048 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 0.894742 | 0.048 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 0.897904 | 0.047 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 0.897904 | 0.047 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 0.898489 | 0.046 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 0.898489 | 0.046 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 0.898489 | 0.046 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 0.898489 | 0.046 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 0.898489 | 0.046 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 0.898489 | 0.046 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 0.898489 | 0.046 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 0.898489 | 0.046 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 0.899454 | 0.046 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 0.899831 | 0.046 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 0.901168 | 0.045 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 0.901168 | 0.045 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 0.901168 | 0.045 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 0.902560 | 0.045 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 0.902560 | 0.045 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 0.904035 | 0.044 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 0.904350 | 0.044 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 0.904634 | 0.044 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 0.905234 | 0.043 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 0.905234 | 0.043 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 0.905234 | 0.043 | 1 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 0.907679 | 0.042 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 0.908384 | 0.042 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 0.908384 | 0.042 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 0.908384 | 0.042 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 0.908973 | 0.041 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 0.908973 | 0.041 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 0.908973 | 0.041 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 0.908973 | 0.041 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 0.908973 | 0.041 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 0.908973 | 0.041 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 0.908973 | 0.041 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 0.908973 | 0.041 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 0.908973 | 0.041 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 0.908973 | 0.041 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 0.908973 | 0.041 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 0.910693 | 0.041 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 0.915118 | 0.039 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 0.915742 | 0.038 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 0.915834 | 0.038 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 0.916806 | 0.038 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 0.916925 | 0.038 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 0.916925 | 0.038 | 1 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 0.918186 | 0.037 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 0.918186 | 0.037 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 0.918374 | 0.037 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 0.918374 | 0.037 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 0.918374 | 0.037 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 0.918374 | 0.037 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 0.918374 | 0.037 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 0.918374 | 0.037 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 0.918374 | 0.037 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 0.918374 | 0.037 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 0.919547 | 0.036 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 0.919547 | 0.036 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 0.919547 | 0.036 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 0.919548 | 0.036 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 0.920589 | 0.036 | 1 | 0 |
| DAP12 interactions | R-HSA-2172127 | 0.921399 | 0.036 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 0.925085 | 0.034 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 0.925085 | 0.034 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 0.926511 | 0.033 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 0.926805 | 0.033 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 0.926805 | 0.033 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 0.926805 | 0.033 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 0.926805 | 0.033 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 0.926805 | 0.033 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 0.926805 | 0.033 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 0.926805 | 0.033 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 0.926805 | 0.033 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 0.927252 | 0.033 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 0.927252 | 0.033 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 0.927252 | 0.033 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 0.927252 | 0.033 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 0.927252 | 0.033 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 0.927779 | 0.033 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 0.927779 | 0.033 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 0.929839 | 0.032 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 0.930423 | 0.031 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 0.931432 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 0.931432 | 0.031 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 0.931432 | 0.031 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 0.931432 | 0.031 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 0.932630 | 0.030 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 0.932630 | 0.030 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 0.932701 | 0.030 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 0.932701 | 0.030 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 0.932701 | 0.030 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 0.932701 | 0.030 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 0.934281 | 0.030 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 0.934366 | 0.029 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 0.934366 | 0.029 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 0.934366 | 0.029 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 0.934366 | 0.029 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 0.934366 | 0.029 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 0.934366 | 0.029 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 0.934366 | 0.029 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 0.934366 | 0.029 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 0.934366 | 0.029 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 0.934366 | 0.029 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 0.934366 | 0.029 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 0.934366 | 0.029 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 0.935993 | 0.029 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 0.937268 | 0.028 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 0.937268 | 0.028 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 0.937268 | 0.028 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 0.937268 | 0.028 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 0.937268 | 0.028 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 0.937268 | 0.028 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 0.937337 | 0.028 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 0.937337 | 0.028 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 0.937773 | 0.028 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 0.937773 | 0.028 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 0.940445 | 0.027 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 0.941146 | 0.026 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 0.941146 | 0.026 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 0.941146 | 0.026 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 0.941146 | 0.026 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 0.941146 | 0.026 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 0.941146 | 0.026 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 0.941146 | 0.026 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 0.941146 | 0.026 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 0.941392 | 0.026 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 0.941672 | 0.026 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 0.941715 | 0.026 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 0.941745 | 0.026 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 0.942489 | 0.026 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 0.942489 | 0.026 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 0.942630 | 0.026 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 0.942630 | 0.026 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 0.943214 | 0.025 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 0.944407 | 0.025 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 0.945731 | 0.024 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 0.945731 | 0.024 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 0.946147 | 0.024 | 1 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 0.946871 | 0.024 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 0.947226 | 0.024 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 0.947226 | 0.024 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 0.947226 | 0.024 | 1 | 1 |
| Attachment and Entry | R-HSA-9694614 | 0.947226 | 0.024 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 0.947226 | 0.024 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 0.947554 | 0.023 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 0.947554 | 0.023 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 0.947554 | 0.023 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 0.947554 | 0.023 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 0.948692 | 0.023 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 0.951185 | 0.022 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 0.951282 | 0.022 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 0.951756 | 0.021 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 0.951756 | 0.021 | 1 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 0.952014 | 0.021 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 0.952074 | 0.021 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 0.952074 | 0.021 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 0.952074 | 0.021 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 0.952678 | 0.021 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 0.952678 | 0.021 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 0.952678 | 0.021 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 0.952678 | 0.021 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 0.953084 | 0.021 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 0.956406 | 0.019 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 0.956987 | 0.019 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 0.957567 | 0.019 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 0.957567 | 0.019 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 0.957567 | 0.019 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 0.957567 | 0.019 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 0.957567 | 0.019 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 0.957567 | 0.019 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 0.957567 | 0.019 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 0.957567 | 0.019 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 0.957567 | 0.019 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 0.957623 | 0.019 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 0.957623 | 0.019 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 0.959200 | 0.018 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 0.959200 | 0.018 | 1 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 0.959351 | 0.018 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 0.960020 | 0.018 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 0.960020 | 0.018 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 0.961952 | 0.017 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 0.961952 | 0.017 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 0.961952 | 0.017 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 0.961952 | 0.017 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 0.963504 | 0.016 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 0.963504 | 0.016 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 0.963575 | 0.016 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 0.963615 | 0.016 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 0.964480 | 0.016 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 0.965112 | 0.015 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 0.965112 | 0.015 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 0.965883 | 0.015 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 0.965883 | 0.015 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 0.965883 | 0.015 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 0.965883 | 0.015 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 0.966694 | 0.015 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 0.966694 | 0.015 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 0.966694 | 0.015 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 0.967267 | 0.014 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 0.967267 | 0.014 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 0.967327 | 0.014 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 0.967377 | 0.014 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 0.967874 | 0.014 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 0.968532 | 0.014 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 0.969409 | 0.013 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 0.969409 | 0.013 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 0.969409 | 0.013 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 0.969615 | 0.013 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 0.969615 | 0.013 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 0.969615 | 0.013 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 0.969847 | 0.013 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 0.972087 | 0.012 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 0.972177 | 0.012 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 0.972570 | 0.012 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 0.972570 | 0.012 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 0.972570 | 0.012 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 0.972570 | 0.012 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 0.972570 | 0.012 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 0.972570 | 0.012 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 0.972570 | 0.012 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 0.974440 | 0.011 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 0.975032 | 0.011 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 0.975405 | 0.011 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 0.975405 | 0.011 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 0.975405 | 0.011 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 0.975405 | 0.011 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 0.975405 | 0.011 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 0.976117 | 0.010 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 0.976195 | 0.010 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 0.976479 | 0.010 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 0.976955 | 0.010 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 0.976970 | 0.010 | 1 | 1 |
| Gap junction trafficking | R-HSA-190828 | 0.976970 | 0.010 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 0.977409 | 0.010 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 0.977947 | 0.010 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 0.977947 | 0.010 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 0.977948 | 0.010 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 0.978363 | 0.009 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 0.979527 | 0.009 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 0.980226 | 0.009 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 0.980995 | 0.008 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 0.981391 | 0.008 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 0.982270 | 0.008 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 0.982475 | 0.008 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 0.983793 | 0.007 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 0.983793 | 0.007 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 0.984103 | 0.007 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 0.984146 | 0.007 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 0.984273 | 0.007 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 0.984417 | 0.007 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 0.984471 | 0.007 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 0.984487 | 0.007 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 0.985264 | 0.006 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 0.985615 | 0.006 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 0.985747 | 0.006 | 0 | 0 |
| Keratan sulfate biosynthesis | R-HSA-2022854 | 0.985747 | 0.006 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 0.986415 | 0.006 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 0.986511 | 0.006 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 0.986865 | 0.006 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 0.987220 | 0.006 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 0.987220 | 0.006 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 0.987220 | 0.006 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 0.988048 | 0.005 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 0.988048 | 0.005 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 0.988541 | 0.005 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 0.988541 | 0.005 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 0.988541 | 0.005 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 0.988541 | 0.005 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 0.988541 | 0.005 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 0.988541 | 0.005 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 0.989128 | 0.005 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 0.989189 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 0.989726 | 0.004 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 0.989726 | 0.004 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 0.989726 | 0.004 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 0.990112 | 0.004 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 0.990285 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 0.990768 | 0.004 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 0.990789 | 0.004 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 0.991467 | 0.004 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 0.991535 | 0.004 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 0.991535 | 0.004 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 0.991741 | 0.004 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 0.991741 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 0.991741 | 0.004 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 0.991741 | 0.004 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 0.992570 | 0.003 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 0.992595 | 0.003 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 0.992708 | 0.003 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 0.993248 | 0.003 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 0.993361 | 0.003 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 0.994048 | 0.003 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 0.994048 | 0.003 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 0.994626 | 0.002 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 0.994663 | 0.002 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 0.994938 | 0.002 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 0.995103 | 0.002 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 0.995215 | 0.002 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 0.995403 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 0.995403 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 0.995418 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 0.995543 | 0.002 | 0 | 0 |
| Protein folding | R-HSA-391251 | 0.995543 | 0.002 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 0.995710 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 0.995710 | 0.002 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 0.996154 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 0.996211 | 0.002 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 0.996513 | 0.002 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 0.996552 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 0.996552 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 0.996552 | 0.002 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 0.996869 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 0.996909 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 0.996909 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 0.997024 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 0.997062 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 0.997229 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 0.997431 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 0.997670 | 0.001 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 0.997691 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 0.997718 | 0.001 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 0.998003 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 0.998003 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 0.998003 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 0.998083 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 0.998262 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 0.998395 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 0.998562 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 0.998706 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 0.998827 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 0.998879 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 0.998879 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 0.999077 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 0.999128 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 0.999128 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 0.999210 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 0.999330 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 0.999330 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 0.999351 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 0.999400 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 0.999400 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 0.999431 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 0.999558 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 0.999612 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 0.999629 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 0.999644 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 0.999648 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 0.999677 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 0.999721 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 0.999721 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 0.999721 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 0.999789 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 0.999820 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 0.999823 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 0.999838 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 0.999839 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 0.999855 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 0.999861 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 0.999866 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 0.999893 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 0.999894 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 0.999908 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 0.999924 | 0.000 | 1 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 0.999925 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 0.999940 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 0.999947 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 0.999957 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 0.999960 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 0.999964 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 0.999969 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 0.999969 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 0.999969 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 0.999971 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 0.999974 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 0.999987 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 0.999993 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 0.999997 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 0.999998 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 0.999998 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 0.999998 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 0.999999 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 0.999999 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 0.999999 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 0.999999 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 0.999999 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 0.999999 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000 | 0.000 | 1 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000 | 0.000 | 1 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000 | 0.000 | 1 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000 | -0.000 | 1 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000 | -0.000 | 1 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.293988e-10 | 9.639 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.907195e-10 | 9.408 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.121309e-09 | 8.950 | 1 | 0 |
| M Phase | R-HSA-68886 | 3.279492e-08 | 7.484 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.564726e-08 | 7.341 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.445562e-08 | 7.191 | 1 | 1 |
| Mitotic Prometaphase | R-HSA-68877 | 1.429069e-07 | 6.845 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.919268e-07 | 6.717 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.504616e-07 | 6.346 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.054490e-07 | 6.296 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 6.541061e-07 | 6.184 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.301375e-07 | 6.031 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.053736e-06 | 5.977 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.792686e-06 | 5.746 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.859355e-06 | 5.544 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.371251e-06 | 5.472 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.270448e-06 | 5.138 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.978183e-06 | 5.098 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.845607e-06 | 5.105 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.658465e-06 | 5.063 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.050675e-05 | 4.979 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.102115e-05 | 4.958 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.125874e-05 | 4.949 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.494608e-05 | 4.825 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.543688e-05 | 4.811 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.763035e-05 | 4.754 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.811155e-05 | 4.742 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.965998e-05 | 4.706 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.129857e-05 | 4.672 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.129857e-05 | 4.672 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.261728e-05 | 4.646 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.563624e-05 | 4.591 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.881084e-05 | 4.540 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.115970e-05 | 4.506 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.564876e-05 | 4.448 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.266555e-05 | 4.278 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.356452e-05 | 4.271 | 1 | 0 |
| MTOR signalling | R-HSA-165159 | 5.725034e-05 | 4.242 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.174241e-05 | 4.144 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.035556e-05 | 4.153 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.229573e-05 | 4.085 | 1 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.948252e-05 | 4.002 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.072604e-04 | 3.970 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.072604e-04 | 3.970 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.034866e-04 | 3.985 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.088724e-04 | 3.963 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.179370e-04 | 3.928 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.513699e-04 | 3.820 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.513699e-04 | 3.820 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.605582e-04 | 3.794 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.648656e-04 | 3.783 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.012323e-04 | 3.696 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.169865e-04 | 3.664 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.430303e-04 | 3.614 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.486159e-04 | 3.604 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.329432e-04 | 3.633 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.391859e-04 | 3.621 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.042799e-04 | 3.517 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.046844e-04 | 3.516 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.059348e-04 | 3.514 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.266274e-04 | 3.486 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.499129e-04 | 3.456 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.737346e-04 | 3.427 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.666089e-04 | 3.331 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.057171e-04 | 3.296 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.928764e-04 | 3.307 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.100508e-04 | 3.292 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.264327e-04 | 3.279 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.719044e-04 | 3.243 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.565499e-04 | 3.254 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.796121e-04 | 3.237 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.273285e-04 | 3.203 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 7.719440e-04 | 3.112 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.916793e-04 | 3.101 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.992851e-04 | 3.046 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 9.181713e-04 | 3.037 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.359125e-04 | 3.029 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 9.478286e-04 | 3.023 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 9.478286e-04 | 3.023 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.972279e-04 | 3.001 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.027302e-03 | 2.988 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.086284e-03 | 2.964 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.107710e-03 | 2.956 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.154732e-03 | 2.938 | 1 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.153197e-03 | 2.938 | 1 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.117099e-03 | 2.952 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.188752e-03 | 2.925 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.189278e-03 | 2.925 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.189278e-03 | 2.925 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.219232e-03 | 2.914 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.230358e-03 | 2.910 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.281735e-03 | 2.892 | 1 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.230358e-03 | 2.910 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.303862e-03 | 2.885 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.305058e-03 | 2.884 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.318888e-03 | 2.880 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.351456e-03 | 2.869 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.425169e-03 | 2.846 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.444358e-03 | 2.840 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.721520e-03 | 2.764 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.763075e-03 | 2.754 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.647534e-03 | 2.783 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.824067e-03 | 2.739 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.036578e-03 | 2.691 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.144717e-03 | 2.669 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.234751e-03 | 2.651 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.307943e-03 | 2.637 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.483582e-03 | 2.605 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.541175e-03 | 2.595 | 1 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.862364e-03 | 2.543 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.049549e-03 | 2.516 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.215498e-03 | 2.493 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.314531e-03 | 2.480 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.521075e-03 | 2.453 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.555205e-03 | 2.449 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.555205e-03 | 2.449 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.830734e-03 | 2.417 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.898174e-03 | 2.409 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.525309e-03 | 2.344 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.575722e-03 | 2.340 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.625753e-03 | 2.335 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.625753e-03 | 2.335 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.625753e-03 | 2.335 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.629001e-03 | 2.335 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.949982e-03 | 2.305 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.629408e-03 | 2.250 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.629408e-03 | 2.250 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.629408e-03 | 2.250 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.629408e-03 | 2.250 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.629408e-03 | 2.250 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.629408e-03 | 2.250 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.629408e-03 | 2.250 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.629408e-03 | 2.250 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.629408e-03 | 2.250 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.629408e-03 | 2.250 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.629408e-03 | 2.250 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.402945e-03 | 2.267 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.398251e-03 | 2.268 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.134783e-03 | 2.289 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.134783e-03 | 2.289 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.134783e-03 | 2.289 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.679644e-03 | 2.246 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.864974e-03 | 2.232 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.955320e-03 | 2.225 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.427797e-03 | 2.192 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.611672e-03 | 2.180 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.885633e-03 | 2.162 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.879309e-03 | 2.162 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.236547e-03 | 2.140 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.465483e-03 | 2.127 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.500507e-03 | 2.125 | 1 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.516651e-03 | 2.124 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.547915e-03 | 2.122 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.547915e-03 | 2.122 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.744498e-03 | 2.111 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.752703e-03 | 2.111 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.752703e-03 | 2.111 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.847665e-03 | 2.105 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.078449e-03 | 2.093 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.567712e-03 | 2.067 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 9.443298e-03 | 2.025 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.185038e-03 | 2.037 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.789790e-03 | 2.009 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.789790e-03 | 2.009 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.789790e-03 | 2.009 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 8.837951e-03 | 2.054 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.789790e-03 | 2.009 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.220081e-03 | 2.035 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.718522e-03 | 2.012 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.874152e-03 | 2.052 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.083725e-02 | 1.965 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.140717e-02 | 1.943 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.176882e-02 | 1.929 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.176882e-02 | 1.929 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.205352e-02 | 1.919 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.205352e-02 | 1.919 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.251823e-02 | 1.902 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.265538e-02 | 1.898 | 1 | 1 |
| Signaling by EGFR | R-HSA-177929 | 1.307944e-02 | 1.883 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.322521e-02 | 1.879 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.345836e-02 | 1.871 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.384992e-02 | 1.859 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.384992e-02 | 1.859 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.384992e-02 | 1.859 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.384992e-02 | 1.859 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.384992e-02 | 1.859 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.398077e-02 | 1.854 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.669814e-02 | 1.777 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.669814e-02 | 1.777 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.467678e-02 | 1.833 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.474851e-02 | 1.831 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.486251e-02 | 1.828 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.647640e-02 | 1.783 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.673429e-02 | 1.776 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.703381e-02 | 1.769 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.720337e-02 | 1.764 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.720337e-02 | 1.764 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.720337e-02 | 1.764 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.757656e-02 | 1.755 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.757656e-02 | 1.755 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.757656e-02 | 1.755 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.770045e-02 | 1.752 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.770681e-02 | 1.752 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.852089e-02 | 1.732 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.852112e-02 | 1.732 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.857949e-02 | 1.731 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.861984e-02 | 1.730 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.904302e-02 | 1.720 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.487011e-02 | 1.604 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.487011e-02 | 1.604 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.297526e-02 | 1.639 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.297526e-02 | 1.639 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.168471e-02 | 1.664 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.176554e-02 | 1.662 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.439386e-02 | 1.613 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.276680e-02 | 1.643 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.439386e-02 | 1.613 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.439386e-02 | 1.613 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.176554e-02 | 1.662 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.226302e-02 | 1.652 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.509764e-02 | 1.600 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.526143e-02 | 1.598 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.683451e-02 | 1.571 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.704277e-02 | 1.568 | 1 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.773281e-02 | 1.557 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.806894e-02 | 1.552 | 1 | 1 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.806894e-02 | 1.552 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.806894e-02 | 1.552 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.806894e-02 | 1.552 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.806894e-02 | 1.552 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.806894e-02 | 1.552 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.809870e-02 | 1.551 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.903120e-02 | 1.537 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.930827e-02 | 1.533 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.941635e-02 | 1.531 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.944497e-02 | 1.531 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.955643e-02 | 1.529 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.685322e-02 | 1.434 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.382627e-02 | 1.471 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.074703e-02 | 1.512 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.617733e-02 | 1.442 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.483059e-02 | 1.458 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.137533e-02 | 1.503 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.450527e-02 | 1.462 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.571708e-02 | 1.447 | 1 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.450527e-02 | 1.462 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.685322e-02 | 1.434 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.382627e-02 | 1.471 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.074703e-02 | 1.512 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.242658e-02 | 1.489 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.737692e-02 | 1.427 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.799815e-02 | 1.420 | 1 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.875551e-02 | 1.412 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.995903e-02 | 1.398 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.024200e-02 | 1.395 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.026557e-02 | 1.395 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.026557e-02 | 1.395 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.028099e-02 | 1.395 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.256936e-02 | 1.371 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.303497e-02 | 1.366 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.303497e-02 | 1.366 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.303497e-02 | 1.366 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.654420e-02 | 1.332 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 4.654420e-02 | 1.332 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.498741e-02 | 1.260 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.498741e-02 | 1.260 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.739935e-02 | 1.324 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.739935e-02 | 1.324 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.739935e-02 | 1.324 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.739935e-02 | 1.324 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 5.523437e-02 | 1.258 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.523437e-02 | 1.258 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.592959e-02 | 1.338 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.917889e-02 | 1.308 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.447808e-02 | 1.264 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.267298e-02 | 1.278 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.955797e-02 | 1.305 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.242579e-02 | 1.280 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.352788e-02 | 1.271 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.938759e-02 | 1.306 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.353332e-02 | 1.271 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.643339e-02 | 1.333 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.523437e-02 | 1.258 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.523437e-02 | 1.258 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.052162e-02 | 1.297 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.423685e-02 | 1.354 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.654420e-02 | 1.332 | 1 | 1 |
| Interferon Signaling | R-HSA-913531 | 5.165590e-02 | 1.287 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.132295e-02 | 1.290 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.313895e-02 | 1.275 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.562771e-02 | 1.255 | 1 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.655383e-02 | 1.248 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.655383e-02 | 1.248 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.801082e-02 | 1.236 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.862514e-02 | 1.232 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.945338e-02 | 1.226 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.945338e-02 | 1.226 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 5.994142e-02 | 1.222 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.994142e-02 | 1.222 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.994142e-02 | 1.222 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.994142e-02 | 1.222 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.012847e-02 | 1.221 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.012847e-02 | 1.221 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.046552e-02 | 1.218 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.064527e-02 | 1.217 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.064527e-02 | 1.217 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.141871e-02 | 1.212 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.377177e-02 | 1.195 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.401813e-02 | 1.194 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.556249e-02 | 1.183 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.556249e-02 | 1.183 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.556249e-02 | 1.183 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.556249e-02 | 1.183 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.556249e-02 | 1.183 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.556249e-02 | 1.183 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.613382e-02 | 1.180 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.639382e-02 | 1.178 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.701501e-02 | 1.174 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.701501e-02 | 1.174 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.765254e-02 | 1.170 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.840658e-02 | 1.165 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.887927e-02 | 1.162 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 7.290951e-02 | 1.137 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 7.290951e-02 | 1.137 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 7.290951e-02 | 1.137 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 7.290951e-02 | 1.137 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.300734e-02 | 1.137 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.300734e-02 | 1.137 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.300734e-02 | 1.137 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.492688e-02 | 1.125 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.492688e-02 | 1.125 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.492688e-02 | 1.125 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.492688e-02 | 1.125 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.511036e-02 | 1.124 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.619313e-02 | 1.118 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.711505e-02 | 1.113 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.446544e-02 | 1.073 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 9.924068e-02 | 1.003 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 9.924068e-02 | 1.003 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 9.138637e-02 | 1.039 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 9.138637e-02 | 1.039 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.961224e-02 | 1.048 | 1 | 1 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.961224e-02 | 1.048 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.293172e-02 | 1.081 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.293172e-02 | 1.081 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.288607e-02 | 1.032 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.025514e-01 | 0.989 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.557237e-02 | 1.020 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.006751e-01 | 0.997 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.025514e-01 | 0.989 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.353084e-02 | 1.029 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.373550e-02 | 1.028 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 9.138637e-02 | 1.039 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.353084e-02 | 1.029 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.010461e-02 | 1.045 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.015275e-01 | 0.993 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.209736e-02 | 1.086 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.864737e-02 | 1.052 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 9.924068e-02 | 1.003 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.934519e-02 | 1.049 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 9.924068e-02 | 1.003 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.030132e-01 | 0.987 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.619455e-02 | 1.017 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.766491e-02 | 1.010 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.597455e-02 | 1.018 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.557237e-02 | 1.020 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 9.138637e-02 | 1.039 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.961224e-02 | 1.048 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 9.288607e-02 | 1.032 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.373550e-02 | 1.028 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.143826e-02 | 1.089 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.083310e-01 | 0.965 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.091926e-01 | 0.962 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.091926e-01 | 0.962 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.091926e-01 | 0.962 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.091926e-01 | 0.962 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.096702e-01 | 0.960 | 1 | 1 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.103354e-01 | 0.957 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.111506e-01 | 0.954 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.118549e-01 | 0.951 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.127207e-01 | 0.948 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.127207e-01 | 0.948 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.155677e-01 | 0.937 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.166400e-01 | 0.933 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.166400e-01 | 0.933 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.169600e-01 | 0.932 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.171937e-01 | 0.931 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.172701e-01 | 0.931 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.172701e-01 | 0.931 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.172701e-01 | 0.931 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.181674e-01 | 0.928 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.202482e-01 | 0.920 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.267934e-01 | 0.897 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.277394e-01 | 0.894 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.277394e-01 | 0.894 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.277394e-01 | 0.894 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.277394e-01 | 0.894 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.277394e-01 | 0.894 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.282099e-01 | 0.892 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.291720e-01 | 0.889 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.327039e-01 | 0.877 | 1 | 1 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.345131e-01 | 0.871 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 1.347111e-01 | 0.871 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.363463e-01 | 0.865 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.368107e-01 | 0.864 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.372604e-01 | 0.862 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.405355e-01 | 0.852 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.409112e-01 | 0.851 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.409112e-01 | 0.851 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.420917e-01 | 0.847 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.422471e-01 | 0.847 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.422471e-01 | 0.847 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.426232e-01 | 0.846 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.441454e-01 | 0.841 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.457934e-01 | 0.836 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.461021e-01 | 0.835 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.481339e-01 | 0.829 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.481339e-01 | 0.829 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.482984e-01 | 0.829 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.501340e-01 | 0.824 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.525915e-01 | 0.816 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.525915e-01 | 0.816 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.538872e-01 | 0.813 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.551024e-01 | 0.809 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.556450e-01 | 0.808 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.558686e-01 | 0.807 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.558686e-01 | 0.807 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.558686e-01 | 0.807 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.573432e-01 | 0.803 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.618011e-01 | 0.791 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.618011e-01 | 0.791 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.618011e-01 | 0.791 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.618011e-01 | 0.791 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.326083e-01 | 0.633 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.326083e-01 | 0.633 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.326083e-01 | 0.633 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.326083e-01 | 0.633 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.578523e-01 | 0.802 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.578523e-01 | 0.802 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.578523e-01 | 0.802 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.578523e-01 | 0.802 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.578523e-01 | 0.802 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.891038e-01 | 0.723 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.210871e-01 | 0.655 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.693169e-01 | 0.771 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.693169e-01 | 0.771 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.646215e-01 | 0.784 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.135887e-01 | 0.670 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.817289e-01 | 0.741 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.365742e-01 | 0.626 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.365742e-01 | 0.626 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.365742e-01 | 0.626 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.993905e-01 | 0.700 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.175402e-01 | 0.662 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.164378e-01 | 0.665 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.750953e-01 | 0.757 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.937366e-01 | 0.713 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.814096e-01 | 0.741 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.654392e-01 | 0.781 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.922117e-01 | 0.716 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.993905e-01 | 0.700 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.911258e-01 | 0.719 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.833957e-01 | 0.737 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.801791e-01 | 0.744 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.801791e-01 | 0.744 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.815879e-01 | 0.741 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.210871e-01 | 0.655 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.210871e-01 | 0.655 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.815879e-01 | 0.741 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.175402e-01 | 0.662 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.693169e-01 | 0.771 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.132043e-01 | 0.671 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.087518e-01 | 0.680 | 1 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.693169e-01 | 0.771 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.955730e-01 | 0.709 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.700020e-01 | 0.770 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.164378e-01 | 0.665 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.210871e-01 | 0.655 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.661920e-01 | 0.779 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.968361e-01 | 0.706 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.609685e-01 | 0.793 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.132043e-01 | 0.671 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.326083e-01 | 0.633 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.326083e-01 | 0.633 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.210871e-01 | 0.655 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.693169e-01 | 0.771 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.687040e-01 | 0.773 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.919716e-01 | 0.717 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.711453e-01 | 0.767 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.135887e-01 | 0.670 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.115045e-01 | 0.675 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.365742e-01 | 0.626 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.646215e-01 | 0.784 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.353814e-01 | 0.628 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.891038e-01 | 0.723 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.135887e-01 | 0.670 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.290740e-01 | 0.640 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.654392e-01 | 0.781 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.326083e-01 | 0.633 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.578523e-01 | 0.802 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.365742e-01 | 0.626 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.087518e-01 | 0.680 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.700020e-01 | 0.770 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.911258e-01 | 0.719 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.833957e-01 | 0.737 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.210871e-01 | 0.655 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.210871e-01 | 0.655 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.239826e-01 | 0.650 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.743552e-01 | 0.759 | 1 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.329932e-01 | 0.633 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.334284e-01 | 0.632 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.331518e-01 | 0.632 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.879781e-01 | 0.726 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.132043e-01 | 0.671 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.419529e-01 | 0.616 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.470340e-01 | 0.607 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.974379e-01 | 0.527 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 2.974379e-01 | 0.527 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.974379e-01 | 0.527 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.974379e-01 | 0.527 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.974379e-01 | 0.527 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.974379e-01 | 0.527 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.567943e-01 | 0.448 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.567943e-01 | 0.448 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.567943e-01 | 0.448 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.567943e-01 | 0.448 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.534560e-01 | 0.596 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.534560e-01 | 0.596 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 2.534560e-01 | 0.596 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.859173e-01 | 0.544 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.859173e-01 | 0.544 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.111391e-01 | 0.386 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.111391e-01 | 0.386 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.111391e-01 | 0.386 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.111391e-01 | 0.386 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.111391e-01 | 0.386 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 3.182246e-01 | 0.497 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.599571e-01 | 0.585 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.599571e-01 | 0.585 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 3.501726e-01 | 0.456 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 4.608952e-01 | 0.336 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.608952e-01 | 0.336 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.608952e-01 | 0.336 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.608952e-01 | 0.336 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.815915e-01 | 0.418 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.815915e-01 | 0.418 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.815915e-01 | 0.418 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.313464e-01 | 0.480 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.552143e-01 | 0.450 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.552143e-01 | 0.450 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.123427e-01 | 0.385 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.123427e-01 | 0.385 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.123427e-01 | 0.385 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.123427e-01 | 0.385 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.123427e-01 | 0.385 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.123427e-01 | 0.385 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.969176e-01 | 0.527 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.330555e-01 | 0.477 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.330555e-01 | 0.477 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.330555e-01 | 0.477 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.819975e-01 | 0.550 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.789672e-01 | 0.421 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.558141e-01 | 0.592 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.528377e-01 | 0.452 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.528377e-01 | 0.452 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.423150e-01 | 0.354 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.025268e-01 | 0.395 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.025268e-01 | 0.395 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.726211e-01 | 0.429 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.726211e-01 | 0.429 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.714204e-01 | 0.327 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.714204e-01 | 0.327 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.667634e-01 | 0.574 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.119952e-01 | 0.385 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.487921e-01 | 0.348 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.999936e-01 | 0.398 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.654152e-01 | 0.437 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.314955e-01 | 0.365 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 4.995915e-01 | 0.301 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.995915e-01 | 0.301 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.995915e-01 | 0.301 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.706715e-01 | 0.431 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.508163e-01 | 0.346 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.508163e-01 | 0.346 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.153878e-01 | 0.501 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.356941e-01 | 0.361 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.510382e-01 | 0.346 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.510382e-01 | 0.346 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.887740e-01 | 0.311 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.887740e-01 | 0.311 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.662869e-01 | 0.331 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.496117e-01 | 0.347 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.814207e-01 | 0.317 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.592682e-01 | 0.338 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.013293e-01 | 0.300 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.013293e-01 | 0.300 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.206907e-01 | 0.376 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.964213e-01 | 0.304 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.964213e-01 | 0.304 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.964213e-01 | 0.304 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.853221e-01 | 0.314 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.074499e-01 | 0.512 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.999936e-01 | 0.398 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.923559e-01 | 0.406 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.133967e-01 | 0.384 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.599571e-01 | 0.585 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.592682e-01 | 0.338 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.182246e-01 | 0.497 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.815915e-01 | 0.418 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.699204e-01 | 0.328 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.274659e-01 | 0.485 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.365006e-01 | 0.360 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 2.534560e-01 | 0.596 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.182246e-01 | 0.497 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.182246e-01 | 0.497 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.599571e-01 | 0.585 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.074499e-01 | 0.512 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.800780e-01 | 0.553 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.887740e-01 | 0.311 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.796258e-01 | 0.319 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.859173e-01 | 0.544 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.079984e-01 | 0.389 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.935369e-01 | 0.307 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.355494e-01 | 0.361 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.783971e-01 | 0.555 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.123427e-01 | 0.385 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.954909e-01 | 0.529 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.668468e-01 | 0.574 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.802162e-01 | 0.420 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.599571e-01 | 0.585 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.993339e-01 | 0.399 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.608952e-01 | 0.336 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.074499e-01 | 0.512 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.815915e-01 | 0.418 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.634368e-01 | 0.579 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.634368e-01 | 0.579 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.819975e-01 | 0.550 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.714204e-01 | 0.327 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.512809e-01 | 0.346 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.365006e-01 | 0.360 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.504282e-01 | 0.346 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.310361e-01 | 0.480 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.922460e-01 | 0.308 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.937969e-01 | 0.405 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.937969e-01 | 0.405 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.937969e-01 | 0.405 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.937969e-01 | 0.405 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.979583e-01 | 0.303 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.579183e-01 | 0.589 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.182246e-01 | 0.497 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.608952e-01 | 0.336 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.634368e-01 | 0.579 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.789672e-01 | 0.421 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.487921e-01 | 0.348 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.795963e-01 | 0.421 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.724540e-01 | 0.429 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.680692e-01 | 0.572 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.970135e-01 | 0.527 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.229829e-01 | 0.374 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.783971e-01 | 0.555 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.644566e-01 | 0.333 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.133277e-01 | 0.504 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.528377e-01 | 0.452 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.726211e-01 | 0.429 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 4.512809e-01 | 0.346 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.887740e-01 | 0.311 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.576477e-01 | 0.339 | 1 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.742604e-01 | 0.562 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.274659e-01 | 0.485 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.123427e-01 | 0.385 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.330555e-01 | 0.477 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.508163e-01 | 0.346 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.139164e-01 | 0.503 | 1 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.313464e-01 | 0.480 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.819975e-01 | 0.550 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 2.974379e-01 | 0.527 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.974379e-01 | 0.527 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 3.567943e-01 | 0.448 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.534560e-01 | 0.596 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.859173e-01 | 0.544 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.111391e-01 | 0.386 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.182246e-01 | 0.497 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.836192e-01 | 0.547 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 3.501726e-01 | 0.456 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.608952e-01 | 0.336 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 4.608952e-01 | 0.336 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.608952e-01 | 0.336 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.742604e-01 | 0.562 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.634368e-01 | 0.579 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.969176e-01 | 0.527 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.482391e-01 | 0.458 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.512730e-01 | 0.454 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.737906e-01 | 0.427 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.964213e-01 | 0.304 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.748046e-01 | 0.561 | 1 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.736477e-01 | 0.428 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.926939e-01 | 0.406 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.310361e-01 | 0.480 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.937969e-01 | 0.405 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.133277e-01 | 0.504 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.563824e-01 | 0.448 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.127144e-01 | 0.384 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.444870e-01 | 0.463 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.310361e-01 | 0.480 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 4.608952e-01 | 0.336 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.784008e-01 | 0.320 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.171822e-01 | 0.380 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.182246e-01 | 0.497 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.133277e-01 | 0.504 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.580502e-01 | 0.588 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.580502e-01 | 0.588 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.795963e-01 | 0.421 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.482391e-01 | 0.458 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.139288e-01 | 0.503 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.671586e-01 | 0.573 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.221824e-01 | 0.374 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.859173e-01 | 0.544 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.111391e-01 | 0.386 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.608952e-01 | 0.336 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.123427e-01 | 0.385 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.123427e-01 | 0.385 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.123427e-01 | 0.385 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.838257e-01 | 0.416 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.712881e-01 | 0.567 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.591050e-01 | 0.445 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.859173e-01 | 0.544 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.363674e-01 | 0.360 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.389783e-01 | 0.358 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.431181e-01 | 0.465 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 3.074499e-01 | 0.512 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.501395e-01 | 0.456 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.139164e-01 | 0.503 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.221824e-01 | 0.374 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.310361e-01 | 0.480 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.567943e-01 | 0.448 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.111391e-01 | 0.386 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.608952e-01 | 0.336 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 4.608952e-01 | 0.336 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 4.608952e-01 | 0.336 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.423150e-01 | 0.354 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.487921e-01 | 0.348 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.937969e-01 | 0.405 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.875480e-01 | 0.312 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.996962e-01 | 0.398 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.258226e-01 | 0.371 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.797133e-01 | 0.553 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.525245e-01 | 0.598 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.995915e-01 | 0.301 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.507593e-01 | 0.455 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.512809e-01 | 0.346 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 2.534560e-01 | 0.596 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.501726e-01 | 0.456 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.487921e-01 | 0.348 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.650167e-01 | 0.577 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.804888e-01 | 0.552 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.789672e-01 | 0.421 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.893005e-01 | 0.410 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.838257e-01 | 0.416 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.952996e-01 | 0.403 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.567943e-01 | 0.448 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 2.534560e-01 | 0.596 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.182246e-01 | 0.497 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.608952e-01 | 0.336 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.634368e-01 | 0.579 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.423150e-01 | 0.354 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.680692e-01 | 0.572 | 1 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.827521e-01 | 0.417 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.713797e-01 | 0.327 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.681354e-01 | 0.330 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.838257e-01 | 0.416 | 1 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.123427e-01 | 0.385 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.423150e-01 | 0.354 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.699204e-01 | 0.328 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.487921e-01 | 0.348 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.611236e-01 | 0.442 | 1 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.859173e-01 | 0.544 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.608952e-01 | 0.336 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.815915e-01 | 0.418 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.139017e-01 | 0.383 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.623811e-01 | 0.441 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.356941e-01 | 0.361 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.608952e-01 | 0.336 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.123427e-01 | 0.385 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.931075e-01 | 0.307 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.182246e-01 | 0.497 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.423150e-01 | 0.354 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.714204e-01 | 0.327 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.046704e-01 | 0.393 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.123427e-01 | 0.385 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.059779e-01 | 0.296 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.064499e-01 | 0.295 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.064499e-01 | 0.295 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.064499e-01 | 0.295 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.064499e-01 | 0.295 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.064499e-01 | 0.295 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.064499e-01 | 0.295 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.064499e-01 | 0.295 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.064499e-01 | 0.295 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.064499e-01 | 0.295 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.064499e-01 | 0.295 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.064499e-01 | 0.295 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.064499e-01 | 0.295 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.064499e-01 | 0.295 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.093920e-01 | 0.293 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.099050e-01 | 0.293 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.112711e-01 | 0.291 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.122317e-01 | 0.291 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.122317e-01 | 0.291 | 1 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.154249e-01 | 0.288 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.176236e-01 | 0.286 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.256090e-01 | 0.279 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.256090e-01 | 0.279 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.267785e-01 | 0.278 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.267785e-01 | 0.278 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.267785e-01 | 0.278 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.267785e-01 | 0.278 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.267785e-01 | 0.278 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.267785e-01 | 0.278 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.267816e-01 | 0.278 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.288600e-01 | 0.277 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.288600e-01 | 0.277 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.331709e-01 | 0.273 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.336437e-01 | 0.273 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.336437e-01 | 0.273 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.342973e-01 | 0.272 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.363994e-01 | 0.271 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.363994e-01 | 0.271 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.363994e-01 | 0.271 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.404552e-01 | 0.267 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.448893e-01 | 0.264 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.463627e-01 | 0.263 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.463627e-01 | 0.263 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.481576e-01 | 0.261 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.481576e-01 | 0.261 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.481576e-01 | 0.261 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.481576e-01 | 0.261 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.481576e-01 | 0.261 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.481576e-01 | 0.261 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.481576e-01 | 0.261 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.481576e-01 | 0.261 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.481576e-01 | 0.261 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.481576e-01 | 0.261 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.495070e-01 | 0.260 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.495070e-01 | 0.260 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.529465e-01 | 0.257 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.529465e-01 | 0.257 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.529465e-01 | 0.257 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.529465e-01 | 0.257 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.529465e-01 | 0.257 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.547331e-01 | 0.256 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.570390e-01 | 0.254 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.570390e-01 | 0.254 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.570390e-01 | 0.254 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.570390e-01 | 0.254 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.611110e-01 | 0.251 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.650616e-01 | 0.248 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.724927e-01 | 0.242 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.754512e-01 | 0.240 | 1 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.771163e-01 | 0.239 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.771163e-01 | 0.239 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.771163e-01 | 0.239 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.780735e-01 | 0.238 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.780735e-01 | 0.238 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.783092e-01 | 0.238 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.783092e-01 | 0.238 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.789137e-01 | 0.237 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.803376e-01 | 0.236 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.827318e-01 | 0.235 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.827318e-01 | 0.235 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.863431e-01 | 0.232 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.863431e-01 | 0.232 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.863431e-01 | 0.232 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.863431e-01 | 0.232 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.863431e-01 | 0.232 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.863431e-01 | 0.232 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.863431e-01 | 0.232 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.863431e-01 | 0.232 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.863431e-01 | 0.232 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 5.863431e-01 | 0.232 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.863431e-01 | 0.232 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.863431e-01 | 0.232 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 5.863431e-01 | 0.232 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.863431e-01 | 0.232 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.879096e-01 | 0.231 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.915656e-01 | 0.228 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.919185e-01 | 0.228 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.951159e-01 | 0.225 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.951159e-01 | 0.225 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.951159e-01 | 0.225 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.951159e-01 | 0.225 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.951159e-01 | 0.225 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.951159e-01 | 0.225 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.966118e-01 | 0.224 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.966118e-01 | 0.224 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.966118e-01 | 0.224 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.966118e-01 | 0.224 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.966118e-01 | 0.224 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 5.966118e-01 | 0.224 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.978927e-01 | 0.223 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.997834e-01 | 0.222 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.008146e-01 | 0.221 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.012065e-01 | 0.221 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.016176e-01 | 0.221 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.021487e-01 | 0.220 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.021487e-01 | 0.220 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.021487e-01 | 0.220 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.021487e-01 | 0.220 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.021487e-01 | 0.220 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.032794e-01 | 0.219 | 1 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.054155e-01 | 0.218 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.073953e-01 | 0.217 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.085569e-01 | 0.216 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.097784e-01 | 0.215 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.100029e-01 | 0.215 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.100029e-01 | 0.215 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.115172e-01 | 0.214 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.115172e-01 | 0.214 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.140066e-01 | 0.212 | 1 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.155104e-01 | 0.211 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.155104e-01 | 0.211 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.155104e-01 | 0.211 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.213036e-01 | 0.207 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.213036e-01 | 0.207 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.213036e-01 | 0.207 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.213036e-01 | 0.207 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.213036e-01 | 0.207 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.213036e-01 | 0.207 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.213036e-01 | 0.207 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.213036e-01 | 0.207 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.213036e-01 | 0.207 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.213036e-01 | 0.207 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.213036e-01 | 0.207 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.213036e-01 | 0.207 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.213036e-01 | 0.207 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.233140e-01 | 0.205 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.233140e-01 | 0.205 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.233140e-01 | 0.205 | 1 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.242255e-01 | 0.205 | 1 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.243703e-01 | 0.205 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.243703e-01 | 0.205 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.251704e-01 | 0.204 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.251704e-01 | 0.204 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.251704e-01 | 0.204 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.251704e-01 | 0.204 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.251704e-01 | 0.204 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.251704e-01 | 0.204 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.275016e-01 | 0.202 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.275016e-01 | 0.202 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.275016e-01 | 0.202 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.275016e-01 | 0.202 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.338013e-01 | 0.198 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.344780e-01 | 0.198 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.384154e-01 | 0.195 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.404400e-01 | 0.194 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.471446e-01 | 0.189 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.471446e-01 | 0.189 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.471446e-01 | 0.189 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.471446e-01 | 0.189 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.471446e-01 | 0.189 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.484578e-01 | 0.188 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.514772e-01 | 0.186 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.533112e-01 | 0.185 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.533112e-01 | 0.185 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.533112e-01 | 0.185 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.533112e-01 | 0.185 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.533112e-01 | 0.185 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.533112e-01 | 0.185 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.533112e-01 | 0.185 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.533112e-01 | 0.185 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.533112e-01 | 0.185 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.533112e-01 | 0.185 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.533112e-01 | 0.185 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.533112e-01 | 0.185 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.533112e-01 | 0.185 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.558369e-01 | 0.183 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.577805e-01 | 0.182 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.581841e-01 | 0.182 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.581841e-01 | 0.182 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.630040e-01 | 0.178 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.636503e-01 | 0.178 | 1 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.680840e-01 | 0.175 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.680840e-01 | 0.175 | 1 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.680840e-01 | 0.175 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.680840e-01 | 0.175 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.680840e-01 | 0.175 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.680840e-01 | 0.175 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.680840e-01 | 0.175 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.685345e-01 | 0.175 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.789757e-01 | 0.168 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.826154e-01 | 0.166 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.826154e-01 | 0.166 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.826154e-01 | 0.166 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.826154e-01 | 0.166 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.826154e-01 | 0.166 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.826154e-01 | 0.166 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.826154e-01 | 0.166 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.826154e-01 | 0.166 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.826154e-01 | 0.166 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.826154e-01 | 0.166 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.849726e-01 | 0.164 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.871130e-01 | 0.163 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.871130e-01 | 0.163 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.871130e-01 | 0.163 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.880063e-01 | 0.162 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.880063e-01 | 0.162 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 6.880063e-01 | 0.162 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.912445e-01 | 0.160 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.912445e-01 | 0.160 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.962367e-01 | 0.157 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.007935e-01 | 0.154 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.007935e-01 | 0.154 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.007935e-01 | 0.154 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.007935e-01 | 0.154 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.007935e-01 | 0.154 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.009122e-01 | 0.154 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.009122e-01 | 0.154 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.069192e-01 | 0.151 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.069340e-01 | 0.151 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.069340e-01 | 0.151 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.069340e-01 | 0.151 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.069340e-01 | 0.151 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.069340e-01 | 0.151 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.069340e-01 | 0.151 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.069340e-01 | 0.151 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.071022e-01 | 0.151 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.071022e-01 | 0.151 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.094441e-01 | 0.149 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.094441e-01 | 0.149 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.094441e-01 | 0.149 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.094441e-01 | 0.149 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.094441e-01 | 0.149 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.094441e-01 | 0.149 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.094441e-01 | 0.149 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.094441e-01 | 0.149 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.094441e-01 | 0.149 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.094441e-01 | 0.149 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.094441e-01 | 0.149 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 7.094441e-01 | 0.149 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.094441e-01 | 0.149 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.094441e-01 | 0.149 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.094441e-01 | 0.149 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.107099e-01 | 0.148 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.128153e-01 | 0.147 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.129746e-01 | 0.147 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.142671e-01 | 0.146 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.155931e-01 | 0.145 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.160017e-01 | 0.145 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.160017e-01 | 0.145 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.160017e-01 | 0.145 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.167317e-01 | 0.145 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.192858e-01 | 0.143 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.216325e-01 | 0.142 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.231071e-01 | 0.141 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.235547e-01 | 0.141 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.248929e-01 | 0.140 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.248929e-01 | 0.140 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.248929e-01 | 0.140 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.248929e-01 | 0.140 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.248929e-01 | 0.140 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.248929e-01 | 0.140 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.248929e-01 | 0.140 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.271788e-01 | 0.138 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 7.272448e-01 | 0.138 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.306040e-01 | 0.136 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.340065e-01 | 0.134 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.340065e-01 | 0.134 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.340065e-01 | 0.134 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.340065e-01 | 0.134 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.340065e-01 | 0.134 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.340065e-01 | 0.134 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 7.340065e-01 | 0.134 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.340065e-01 | 0.134 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.340065e-01 | 0.134 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.340065e-01 | 0.134 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.340065e-01 | 0.134 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.340065e-01 | 0.134 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.340065e-01 | 0.134 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.340065e-01 | 0.134 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.340065e-01 | 0.134 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.340065e-01 | 0.134 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.340065e-01 | 0.134 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.348874e-01 | 0.134 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.348874e-01 | 0.134 | 1 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.363290e-01 | 0.133 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.385482e-01 | 0.132 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.394758e-01 | 0.131 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.419113e-01 | 0.130 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.419113e-01 | 0.130 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.419113e-01 | 0.130 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.495048e-01 | 0.125 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.495048e-01 | 0.125 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.495672e-01 | 0.125 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.516838e-01 | 0.124 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.516838e-01 | 0.124 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.548745e-01 | 0.122 | 1 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.564938e-01 | 0.121 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.564938e-01 | 0.121 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.564938e-01 | 0.121 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.564938e-01 | 0.121 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.564938e-01 | 0.121 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.564938e-01 | 0.121 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 7.564938e-01 | 0.121 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 7.564938e-01 | 0.121 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.564938e-01 | 0.121 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.564938e-01 | 0.121 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 7.564938e-01 | 0.121 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.564938e-01 | 0.121 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.564938e-01 | 0.121 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.564938e-01 | 0.121 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.580199e-01 | 0.120 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.580199e-01 | 0.120 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.580199e-01 | 0.120 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.580199e-01 | 0.120 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.580199e-01 | 0.120 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.580199e-01 | 0.120 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.580199e-01 | 0.120 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.580199e-01 | 0.120 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.580263e-01 | 0.120 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.580263e-01 | 0.120 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.588279e-01 | 0.120 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.588279e-01 | 0.120 | 1 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.620578e-01 | 0.118 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.688597e-01 | 0.114 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.688916e-01 | 0.114 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.700278e-01 | 0.113 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.708682e-01 | 0.113 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.732510e-01 | 0.112 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.732510e-01 | 0.112 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.732510e-01 | 0.112 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.744605e-01 | 0.111 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.744605e-01 | 0.111 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.744605e-01 | 0.111 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.744605e-01 | 0.111 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.754680e-01 | 0.110 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 7.770812e-01 | 0.110 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.770812e-01 | 0.110 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 7.770812e-01 | 0.110 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.770812e-01 | 0.110 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.770812e-01 | 0.110 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.776053e-01 | 0.109 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.781280e-01 | 0.109 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.797575e-01 | 0.108 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.831472e-01 | 0.106 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.831472e-01 | 0.106 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.831472e-01 | 0.106 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.831472e-01 | 0.106 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.831472e-01 | 0.106 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.831472e-01 | 0.106 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.849817e-01 | 0.105 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.860848e-01 | 0.105 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.870837e-01 | 0.104 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.876376e-01 | 0.104 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.876376e-01 | 0.104 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.876376e-01 | 0.104 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 7.876376e-01 | 0.104 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.937965e-01 | 0.100 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.959292e-01 | 0.099 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.959292e-01 | 0.099 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.959292e-01 | 0.099 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.959292e-01 | 0.099 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 7.959292e-01 | 0.099 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.959292e-01 | 0.099 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.959292e-01 | 0.099 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.959292e-01 | 0.099 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.959292e-01 | 0.099 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 7.959292e-01 | 0.099 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.959292e-01 | 0.099 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.959292e-01 | 0.099 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.012137e-01 | 0.096 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.012137e-01 | 0.096 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.032640e-01 | 0.095 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.054946e-01 | 0.094 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.060721e-01 | 0.094 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.099009e-01 | 0.092 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.131845e-01 | 0.090 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.131845e-01 | 0.090 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.131845e-01 | 0.090 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.131845e-01 | 0.090 | 1 | 1 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.131845e-01 | 0.090 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.131845e-01 | 0.090 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.131845e-01 | 0.090 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.131845e-01 | 0.090 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.131845e-01 | 0.090 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.140134e-01 | 0.089 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.140134e-01 | 0.089 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.150352e-01 | 0.089 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.260709e-01 | 0.083 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.260709e-01 | 0.083 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.260709e-01 | 0.083 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.269200e-01 | 0.083 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.269200e-01 | 0.083 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.289818e-01 | 0.081 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.289818e-01 | 0.081 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.289818e-01 | 0.081 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.289818e-01 | 0.081 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.289818e-01 | 0.081 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.289818e-01 | 0.081 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.289818e-01 | 0.081 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.289818e-01 | 0.081 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.289818e-01 | 0.081 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.289818e-01 | 0.081 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.289818e-01 | 0.081 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.289818e-01 | 0.081 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.357436e-01 | 0.078 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.366046e-01 | 0.077 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.366046e-01 | 0.077 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.374203e-01 | 0.077 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.374203e-01 | 0.077 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.374203e-01 | 0.077 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.374203e-01 | 0.077 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.374203e-01 | 0.077 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.382576e-01 | 0.077 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.413695e-01 | 0.075 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.413695e-01 | 0.075 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.413695e-01 | 0.075 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.434441e-01 | 0.074 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.434441e-01 | 0.074 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.434441e-01 | 0.074 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.434441e-01 | 0.074 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.448185e-01 | 0.073 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.448185e-01 | 0.073 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.458180e-01 | 0.073 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.458180e-01 | 0.073 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.458180e-01 | 0.073 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.458180e-01 | 0.073 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.481524e-01 | 0.072 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.494174e-01 | 0.071 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.545767e-01 | 0.068 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.545767e-01 | 0.068 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.545767e-01 | 0.068 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.566842e-01 | 0.067 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.566842e-01 | 0.067 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.566842e-01 | 0.067 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 8.566842e-01 | 0.067 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.566842e-01 | 0.067 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.566842e-01 | 0.067 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 8.566842e-01 | 0.067 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.566842e-01 | 0.067 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.566842e-01 | 0.067 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.571170e-01 | 0.067 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.581277e-01 | 0.066 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.581277e-01 | 0.066 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.590197e-01 | 0.066 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.635928e-01 | 0.064 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.660210e-01 | 0.062 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.675509e-01 | 0.062 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.675509e-01 | 0.062 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.675509e-01 | 0.062 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.675509e-01 | 0.062 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.675509e-01 | 0.062 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.688053e-01 | 0.061 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.688053e-01 | 0.061 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.688053e-01 | 0.061 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.688053e-01 | 0.061 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.688053e-01 | 0.061 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 8.688053e-01 | 0.061 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.688053e-01 | 0.061 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.688053e-01 | 0.061 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.688053e-01 | 0.061 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.689494e-01 | 0.061 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.763958e-01 | 0.057 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.763958e-01 | 0.057 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.763958e-01 | 0.057 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.763958e-01 | 0.057 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.763958e-01 | 0.057 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.773754e-01 | 0.057 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.782294e-01 | 0.056 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.782904e-01 | 0.056 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.782904e-01 | 0.056 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.799019e-01 | 0.056 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.799019e-01 | 0.056 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.799019e-01 | 0.056 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.799019e-01 | 0.056 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.799019e-01 | 0.056 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 8.799019e-01 | 0.056 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.799019e-01 | 0.056 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.799019e-01 | 0.056 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.799019e-01 | 0.056 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.828976e-01 | 0.054 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.846928e-01 | 0.053 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.846928e-01 | 0.053 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.846928e-01 | 0.053 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.847076e-01 | 0.053 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.847076e-01 | 0.053 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.847076e-01 | 0.053 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.851364e-01 | 0.053 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.871141e-01 | 0.052 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.887784e-01 | 0.051 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.897050e-01 | 0.051 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.900605e-01 | 0.051 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.900605e-01 | 0.051 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.900605e-01 | 0.051 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.900605e-01 | 0.051 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.900605e-01 | 0.051 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.900605e-01 | 0.051 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.900605e-01 | 0.051 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.900605e-01 | 0.051 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.900605e-01 | 0.051 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.900605e-01 | 0.051 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.900605e-01 | 0.051 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.900605e-01 | 0.051 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.900605e-01 | 0.051 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.903828e-01 | 0.050 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.924713e-01 | 0.049 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.924713e-01 | 0.049 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.924713e-01 | 0.049 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.958636e-01 | 0.048 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.985034e-01 | 0.046 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.985034e-01 | 0.046 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.992908e-01 | 0.046 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.993604e-01 | 0.046 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.993604e-01 | 0.046 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 8.993604e-01 | 0.046 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.993604e-01 | 0.046 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 8.993604e-01 | 0.046 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.993604e-01 | 0.046 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.997595e-01 | 0.046 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.997595e-01 | 0.046 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.021353e-01 | 0.045 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.027289e-01 | 0.044 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.037036e-01 | 0.044 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.045374e-01 | 0.044 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.065848e-01 | 0.043 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.065848e-01 | 0.043 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.078741e-01 | 0.042 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.078741e-01 | 0.042 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.078741e-01 | 0.042 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.078741e-01 | 0.042 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.078741e-01 | 0.042 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.078741e-01 | 0.042 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.078741e-01 | 0.042 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.078741e-01 | 0.042 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.124557e-01 | 0.040 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.129732e-01 | 0.040 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.156410e-01 | 0.038 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.156681e-01 | 0.038 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.156681e-01 | 0.038 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.156681e-01 | 0.038 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.156681e-01 | 0.038 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.156681e-01 | 0.038 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.156681e-01 | 0.038 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.172432e-01 | 0.038 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.188772e-01 | 0.037 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.228031e-01 | 0.035 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.228031e-01 | 0.035 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.228031e-01 | 0.035 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.228031e-01 | 0.035 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.228031e-01 | 0.035 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.228031e-01 | 0.035 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.234245e-01 | 0.035 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.245387e-01 | 0.034 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.245387e-01 | 0.034 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.245387e-01 | 0.034 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.255554e-01 | 0.034 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.261209e-01 | 0.033 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.293348e-01 | 0.032 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.293348e-01 | 0.032 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.293348e-01 | 0.032 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.293348e-01 | 0.032 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.293348e-01 | 0.032 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.293348e-01 | 0.032 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.297625e-01 | 0.032 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.297625e-01 | 0.032 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.297625e-01 | 0.032 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.312237e-01 | 0.031 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.353142e-01 | 0.029 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.353142e-01 | 0.029 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.353142e-01 | 0.029 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.353142e-01 | 0.029 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.353142e-01 | 0.029 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.353142e-01 | 0.029 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.360248e-01 | 0.029 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.392008e-01 | 0.027 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.407880e-01 | 0.027 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.407880e-01 | 0.027 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.419774e-01 | 0.026 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.422490e-01 | 0.026 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.434557e-01 | 0.025 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.434557e-01 | 0.025 | 1 | 1 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.457989e-01 | 0.024 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.457989e-01 | 0.024 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.457989e-01 | 0.024 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.457989e-01 | 0.024 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.457989e-01 | 0.024 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.457989e-01 | 0.024 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.462490e-01 | 0.024 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.474262e-01 | 0.023 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.474262e-01 | 0.023 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.476158e-01 | 0.023 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.478338e-01 | 0.023 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.484938e-01 | 0.023 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.485179e-01 | 0.023 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.503860e-01 | 0.022 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.503860e-01 | 0.022 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.503860e-01 | 0.022 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.503860e-01 | 0.022 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.503860e-01 | 0.022 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.511299e-01 | 0.022 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.545852e-01 | 0.020 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.545852e-01 | 0.020 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.545852e-01 | 0.020 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.554121e-01 | 0.020 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.573245e-01 | 0.019 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.578031e-01 | 0.019 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.578774e-01 | 0.019 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.582334e-01 | 0.019 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.584291e-01 | 0.018 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.584291e-01 | 0.018 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.587176e-01 | 0.018 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.608032e-01 | 0.017 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.608032e-01 | 0.017 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.612771e-01 | 0.017 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.616952e-01 | 0.017 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.619480e-01 | 0.017 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.619480e-01 | 0.017 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.628048e-01 | 0.016 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.630302e-01 | 0.016 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.630302e-01 | 0.016 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.630302e-01 | 0.016 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.635980e-01 | 0.016 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.649642e-01 | 0.015 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.651691e-01 | 0.015 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.651691e-01 | 0.015 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.656932e-01 | 0.015 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.662008e-01 | 0.015 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.662008e-01 | 0.015 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.662008e-01 | 0.015 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.679263e-01 | 0.014 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.679263e-01 | 0.014 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.679263e-01 | 0.014 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 9.681178e-01 | 0.014 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.683870e-01 | 0.014 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.683870e-01 | 0.014 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.708170e-01 | 0.013 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.708170e-01 | 0.013 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.708793e-01 | 0.013 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.708793e-01 | 0.013 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.729778e-01 | 0.012 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.731535e-01 | 0.012 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.732878e-01 | 0.012 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.732878e-01 | 0.012 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.732878e-01 | 0.012 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.732878e-01 | 0.012 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.732878e-01 | 0.012 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.732878e-01 | 0.012 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.732878e-01 | 0.012 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.747651e-01 | 0.011 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.755496e-01 | 0.011 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.755496e-01 | 0.011 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.755496e-01 | 0.011 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.755496e-01 | 0.011 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.766541e-01 | 0.010 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.767453e-01 | 0.010 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.770689e-01 | 0.010 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.776200e-01 | 0.010 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.776200e-01 | 0.010 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.776200e-01 | 0.010 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.776200e-01 | 0.010 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.795151e-01 | 0.009 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.795151e-01 | 0.009 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.795151e-01 | 0.009 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.795151e-01 | 0.009 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.795151e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.799807e-01 | 0.009 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.800021e-01 | 0.009 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.812499e-01 | 0.008 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.813008e-01 | 0.008 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.813008e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.813008e-01 | 0.008 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.814601e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.815470e-01 | 0.008 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.828379e-01 | 0.008 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.828379e-01 | 0.008 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.840729e-01 | 0.007 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.842915e-01 | 0.007 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.842915e-01 | 0.007 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.847802e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.852414e-01 | 0.006 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.856220e-01 | 0.006 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.856220e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.856220e-01 | 0.006 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.856220e-01 | 0.006 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.860409e-01 | 0.006 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.863263e-01 | 0.006 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.865793e-01 | 0.006 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.868399e-01 | 0.006 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.868399e-01 | 0.006 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.868399e-01 | 0.006 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.868399e-01 | 0.006 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.871479e-01 | 0.006 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.879548e-01 | 0.005 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.879548e-01 | 0.005 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.882012e-01 | 0.005 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.884713e-01 | 0.005 | 1 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.899092e-01 | 0.004 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.899092e-01 | 0.004 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.899092e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.899092e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.899399e-01 | 0.004 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.899399e-01 | 0.004 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.906491e-01 | 0.004 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.907642e-01 | 0.004 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.915468e-01 | 0.004 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.915468e-01 | 0.004 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.920201e-01 | 0.003 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.922631e-01 | 0.003 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.922631e-01 | 0.003 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.922631e-01 | 0.003 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.924312e-01 | 0.003 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.924312e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.926151e-01 | 0.003 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.926151e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.931666e-01 | 0.003 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.934526e-01 | 0.003 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.936776e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.938827e-01 | 0.003 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.938827e-01 | 0.003 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.945709e-01 | 0.002 | 0 | 0 |
| Translation | R-HSA-72766 | 9.953884e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.957214e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.957214e-01 | 0.002 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.958378e-01 | 0.002 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.958986e-01 | 0.002 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.965136e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.965249e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.965310e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.965560e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.966197e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.968092e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.971126e-01 | 0.001 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.973116e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.973274e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.974249e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.974368e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.975541e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.975541e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.975541e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.975541e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.977615e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.977615e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.977681e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.977738e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.978958e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.979496e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.979496e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.980299e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.981251e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.982620e-01 | 0.001 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.982841e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.984260e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.985686e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.986695e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.986724e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.986848e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.986848e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.986848e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.987964e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.987964e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.989731e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.990775e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.991491e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.992275e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.992283e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.992395e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.993530e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.994574e-01 | 0.000 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.994602e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.994810e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.995042e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.995226e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.996663e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.996803e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.997089e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.997760e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998644e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998848e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.998882e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998904e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999082e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999232e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999232e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999449e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999568e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999631e-01 | 0.000 | 1 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.999691e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999697e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999849e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999903e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999911e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999931e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999952e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999966e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999972e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999973e-01 | 0.000 | 1 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999982e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999988e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999995e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 1 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.000000e+00 | 0.000 | 1 | 1 |